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Electron transferRecent experimental evidence has replaced the random diffusion model of electron transfer with a model of
supramolecular organisation based upon speciﬁc interactions between individual respiratory complexes. These
supercomplexes were found to be functionally relevant by ﬂux control analysis and to confer a kinetic advantage
to NAD-linked respiration (channelling). However, the Coenzyme Q pool is still required for FAD-linked oxida-
tions and for the proper equilibrium with Coenzyme Q bound in the supercomplex. Channelling in the
cytochrome c region probably also occurs but does not seem to confer a particular kinetic advantage. The supra-
molecular association of individual complexes strongly depends on membrane lipid amount and composition
and is affected by lipid peroxidation; it also seems to be modulated by membrane potential and protein phos-
phorylation. Additional properties of supercomplexes are stabilisation of Complex I, as evidenced by the
destabilising effect on Complex I of mutations in either Complex III or IV, and prevention of excessive generation
of reactive oxygen species. The dynamic character of the supercomplexes allows their involvement in metabolic
adaptations and in control of cellular signalling pathways. This article is part of a Special Issue entitled: Dynamic
and ultrastructure of bioenergetic membranes and their components.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Until the end of the past century, the most widely accepted view of
the oxidative phosphorylation system in mitochondria envisaged a
random organisation of the respiratory chain complexes according
to the random diffusion model of Hackenbrock et al. [1] which, in
turn, is based on the previous enzymatic studies in the Enzyme Institute
in Wisconsin [2]. The year 2000 represented a drastic change that has
switched the current understanding to an organisation in supramolecu-
lar assemblies called supercomplexes or respirasomes. Analysis of amulti-
tude of data in the literature obtained by Blue-Native gel electrophoresis
(BN-PAGE) unambiguously reveals that the complexes involved in
supramolecular association are the three proton-translocating enzymes:
Complex I (NADH:Coenzyme Q reductase), Complex III (ubiquinol:
cytochrome c reductase) and Complex IV (cytochrome c oxidase).
Supercomplexes with various conﬁgurations and stoichiometries occur
in mitochondria from different sources (cf. [3–11]).
Furthermore, there are suggestions that evenhigher levels of organi-
sation may exist (megacomplexes or respiratory strings) [12,13].e-Native gel electrophoresis; CI,
ex IV; CJ, cristae junction; CoQ,
g protein; ETF, electron transfer
tive phosphorylation;ROS, reac-
c and ultrastructure of bioener-
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ova).
ights reserved.The structural evidence for supercomplex association is notmatched
by a corresponding knowledge of their function(s), and several ques-
tions are still open concerning the functional role of such supramolecu-
lar entities. In particular, is the supramolecular organisation of the
respiratory chain such to confer a real kinetic advantage on electron
transfer? Or is it just a structural device stabilising the respiratory pro-
teins butwithout a clear functional role in electron transfer? This review
will examine experimental evidence pertaining to the functions of
supercomplexes.
2. Respiratory supercomplexes are functional
If we look back to the early studies on the isolation and puriﬁcation
of respiratory complexes, we can ﬁnd observations leading against their
random distribution; in fact, during the intermediate puriﬁcation steps
of the individual enzymes, Complex I–Complex III units [14–16] and
Complex II–CompIex III units [17] were obtained; similarly in chloro-
plasts also cytochrome b6f-photosystem I units were described [18].
The natural conclusion is that such units may be preferentially associ-
ated in the native membrane. These units possessed the activities
expected from integration of the respective individual complexes,
and can now be viewed as bona ﬁde supercomplexes.
Because early reports of combined complexes used bile salts, which
can lead to protein aggregations, and associations of complexes were
not detected by antibodies within the membranes [19], not many
researchers paid attention to a potential supramolecular organisation
of the respiratory chain. Stable supercomplexes of Complex III and IV
isolated from Paracoccus denitriﬁcans [20], thermophilic Bacillus PS3
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cial feature of these bacteria. Ozawa et al. [23] proposed the existence of
a stable solid-state assembly of the entire OXPHOS system; on the other
hand, Hochman et al. [24] suggested the existence of dynamic aggre-
gates in equilibrium with freely diffusing complexes. Due however to
the lack of clear experimental evidence, these hypotheses were usually
overlooked.
The ﬁrst clear experimental demonstration of supercomplexes by
BN-PAGE following mild digitonin solubilisation of mitochondria
[3,25] pointed out that several types of association are present between
respiratory complexes I, III and IV. Among the various types of associa-
tion, the I1III2IV1 combination was denominated respirasome because
considered the minimal unit to perform complete respiration from
NADH to oxygen. These units possessed the in-gel activities of the indi-
vidual complexes, however the ﬁrst demonstration that they are indeed
functional and capable of full activity came from the chromatographic
isolation of a functional respirasome from P. denitriﬁcans [26]. The
respirasome contained complexes I, III and IV in a 1:4:4 stoichiometry
and was enriched in Coenzyme Q (CoQ) with respect to the original
membrane, but was considerably deﬁcient in cytochrome c552; for this
reason, although the activity of NADH cytochrome c reductase was
close to that expected from the rate-limiting activity of Complex I, the
whole NADHoxidasewas strongly reducedwith respect to the expected
rate.
The respiratory activity of a respirasome isolated from mammalian
mitochondria was reported by Acín-Pérez et al. [27]. They demon-
strated that BN-PAGE bands containing both CoQ9 (the major CoQ
homologue in rodents) and cytochrome c showed complete NADH
oxidase activity, as measured using a Clark electrode. A mixture of the
bands of the individual complexes I, III, and IV, was inactive. This
study demonstrated that supercomplexes not only are real entities,
but are competent in respiration, and therefore their role must be con-
sistent with their activity, i.e. they must provide some advantage in
electron transfer.
3. Supercomplex association provides a kinetic advantage
Immediately after the discovery of supercomplexes it was pro-
posed that the natural consequence of such assemblies is substrate
channelling or enhanced catalysis in inter-complex electron transfer.
Substrate channelling is the direct transfer of an intermediate
between the active sites of two enzymes catalysing consecutive reac-
tions [28]; in the case of electron transfer, this means direct transfer
of electrons between two consecutive enzymes by successive reduc-
tion and reoxidation of the intermediate without its diffusion in
the bulk medium. In such a case, inter-complex electron transfer be-
comes indistinguishable from intra-complex electron transfer, so that
the so-called mobile intermediates, predicted to exhibit substrate-like
behaviour in the classic view of the random collision model, would
rather be buried in the interface between the two consecutive
complexes.
Some evidence for possible channelling comes from the 3D structure
of themitochondrial supercomplex I1III2IV1 [29]; a unique arrangement
of the three component complexes indicates the pathways alongwhich
ubiquinone and cytochrome c can travel to shuttle electrons between
their respective protein partners [29]. In the above mentioned model,
the Coenzyme Q-binding sites in Complex I and in Complex III face
each other and are separated by a 13-nm gap within the membrane
core of the supercomplex. Coenzyme Q is likely to run a trajectory
through this gap which is presumably ﬁlled with membrane lipids.
Althoff and colleagues also reported the presence of signiﬁcant amounts
of bound phospholipids in the puriﬁed supercomplex frommammalian
mitochondria and demonstrated that cardiolipin is enriched in the
supercomplex compared with bovine heart total lipid. Moreover, HPLC
analysis of the lipid extracts indicated that each supercomplex contains
at least one molecule of ubiquinol [29].3.1. Supercomplex association enhances the rate of electron transfer in the
Coenzyme Q region
The rate of electron transfer between membrane-bound electron
carriers depends on their structural organisation in the membrane. If
two redox enzymes are connected by amobile redox carrier undergoing
long-range diffusion in the medium, the overall reaction rate would
be governed by the frequency of useful collisions between the mobile
carrier and its two redox partners. On the other hand, if the system is
ﬁxed in a solid state arrangement, the frequency of encounters will be
dictated only by the proximity and ﬁxed contacts between the redox
partners (channelling). Let us analyze separately the two situations
with respect to themitochondrial respiratory chain. Fig. 1 schematically
illustrates the difference existing between collision-based electron
transfer and channelling.
3.1.1. Collision-based electron transport: the “pool” behaviour
The functional signiﬁcance of a random distribution of mitochondri-
al complexes had been supported by the kinetic analysis of Kröger and
Klingenberg [30] for the enzymes connected by Coenzyme Q; they
showed that steady-state respiration in submitochondrial particles
from beef heart, using either NADH or succinate as electron donors,
could be modelled as a simple two-enzyme system, the ﬁrst causing
reduction of ubiquinone and the second causing oxidation of ubiquinol.
If diffusion of the quinone and quinol species is much faster than the
chemical reactions of CoQ reduction and oxidation, thequinonebehaves
kinetically as a homogeneous pool. According to this assumption, during
steady-state electron transfer, the overall ﬂux observed (Vobs) will be
determined by the redox state of the quinone and proportional to either
reduced (Qred) or oxidised (Qox) CoQ concentration:
Vobs ¼ Vox Qred=Qtð Þ ¼ Vred Qox=Qtð Þ ð1Þ
where Vox is the rate of ubiquinol oxidation, Vred is the rate of CoQ
reduction and Qt is total CoQ concentration (reduced plus oxidised).
Manipulation of Eq. (1) leads to the pool equation
Vobs ¼ Vred  Voxð Þ= Vred þ Voxð Þ ð2Þ
This expression was veriﬁed under a wide variety of input and out-
put rates and establishes that CoQ distributes electrons randomly
among the CoQ-reducing ﬂavin dehydrogenases and the bc1 complexes,
behaving indeed as a laterally diffusing pool of molecules in a variety of
systems [31–33], discussed by Lenaz and Genova [6,34].
Further evidence was provided by the characteristic effect of
changing Vred or Vox on inhibitor titration curves [35]. In the case of
the CoQ pool and titration of Complex III by antimycin, a convex hy-
perbolic relationship exists between the integrated oxidation rate
(Vobs) and the fraction (x) of Complex III inhibited by antimycin:
Vobs ¼ Vred  Vox  1−xð Þ½ = Vred þ Vox  1−xð Þ½  ð3Þ
On the contrary, a linear relationship is expected in the case of a
stoichiometric association between Complex III and the CoQ-reducing
enzymes. However, the convexity of the inhibition curve in a system
obeying to pool behaviour is also a function of the ratio between
Vred and Vox [35] so that pool behaviour may not be easily recognised
and experimentally distinguished from CoQ-channelling in a system
where Vred≫ Vox.
Most available data on CoQ pool concern succinate oxidation in
submitochondrial particles, whereas fewer data are available for
NADH oxidation. In bovine heart submitochondrial particles, the ob-
served rate of electron transfer between Complex I and Complex III
was found to be comparable to that calculated from the pool equa-
tion [36]. In other mitochondrial systems the rate of Complex I activity
is strongly underestimated, due to the properties of CoQ analogues
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Fig. 1. Schematic models showing ubiquinone as a mediator of the electron transport in the respiratory chain. (Upper panel) Pool behaviour: Coenzyme Q as a freely diffusible
interconnectingmediator (Q pool) among the electron donors (Complex I) and the acceptors (Complex III). Interaction of antimycin (AA)with the respiratory chain causes the “nonlinear”
inhibition curve of substrate oxidation (due tomultiple choices for quinol oxidation by the residual active molecules of Complex III, as indicated also by the dotted arrows). In agreement
with Eq. (3), the relation between the respiratory activity (Vobs/V0) and the amount of antimycin relative to the antimycin-titer (i0/n0) depends on the ratio Vred/Vox; the most hyperbolic
curve is observed with the smallest value (i.e. Vred/Vox = 0.05). (Lower panel) Supercomplex arrangement: the serial mediation by ubiquinone (Q) only within the I–III supramolecular
assembly would result in a linear relation of the respiratory activity to antimycin. V0 = Vobs in the absence of antimycin. Reproduced from Lenaz and Genova [6] with permission.
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absolute values of NADH CoQ reductase activity are to be takenwith ex-
treme caution. A very detailed analysis of the possible errors concerning
the interpretation of the pool equations can be found in Lenaz and
Genova [6,34].
A study dealing with presence of diffusible intermediates in the re-
spiratory chain in intact phosphorylating mitochondria was accom-
plished by the double inhibitor titration technique [39] by Stoner [40]
who showed that in intact coupled mitochondria in state 3 (i.e. synthe-
sizing ATP), inhibition of Complex III withmyxothiazol makes succinate
oxidase less sensitive to theComplex II inhibitor 3′-hexylcarboxin, in ac-
cordance with the existence of a freely diffusible intermediate between
the two steps [39]. Unfortunately in his study Stoner did not perform
similar titrations for search of a diffusible intermediate between Com-
plexes I and III.
As a conclusion wemay state with some certainty that, in beef heart
mitochondria, succinate oxidation exhibits pool behaviour, indicating
the presence of CoQ as a diffusible intermediate between Complex II
and Complex III; on the other hand, the same statement for NADH oxi-
dation is supported by less clear-cut evidence.
Although the pool equation has been developed for CoQ between
dehydrogenases and bc1 complexes, the same reasoning is valid for
cytochrome c that shareswith ubiquinone the postulated role of mobile
substrate-like component of the respiratory chain [41].
Nevertheless, the role of cytochrome cmobility between Complex III
and Complex IV is even more intriguing than that of ubiquinone [42].
Hackenbrock et al. [1] observed that under physiological conditions of
150 mM ionic strength, cytochrome c is readily dissociated from themembrane and undergoes three-dimensional diffusion in the inter-
membrane space [43,44]. In reconstituted enzyme systems in presence
of excess cytochrome c, “pool behaviour” is followed [41]; likewise, the
rotation rates of cytochrome c oxidase reconstituted in lipid vesicles are
not inﬂuenced by simultaneous incorporation of the reductase [45],
suggesting that the two enzymes act as independent entities.
3.1.2. Deviations from pool behaviour
The universal validity of the pool equation has been questioned in
the past, since deviations from pool behaviour were described [8,32].
Gutman [31] investigated the properties of the NADH and succinate
oxidation in submitochondrial particles in relation to the rates of energy-
dependent reverse electron transfer from succinate to NAD+ and of
forward electron transfer from NADH to fumarate, concluding that “the
electronﬂux from succinate dehydrogenase to oxygen (forward electron
transfer towards Complex III) or to NADH dehydrogenase (reverse
electron transfer) employs the same carrier and is controlled by the
same reaction” whereas “the electron transfer from NADH to oxygen
does not share the same pathway through which electrons ﬂow in the
NADH-fumarate reductase”. In other words, Complex I and Complex II
are linked by a different pathway with respect to Complex I and Com-
plex III (Fig. 2).
The non-homogeneity of the ubiquinone pool with respect to succi-
nate and NADH oxidation [31] may be interpreted today in terms of
compartmentalisation of CoQ in the I–III supercomplex in contrast
with the free pool used for connecting Complexes II and III.
Kröger and Klingenberg [30,35] already noticed that 10–20% of CoQ
















Fig. 2. Postulated interactions between Complex II and Complex I. Left:Reduction of NAD+by succinate by energy-dependent reverse electron transfer;middle:NADH-fumarate reductase;
right: as a comparison, it is shown the interaction of Complex I with Complex III within the supercomplex. See text for explanations.
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of CoQ in rat liver and muscle mitochondria: one pool is utilised during
succinate-dependent steady-state respiration, another (approx. 8% in
muscle and 23% in liver) is mobilised as a reserve in case of a perturba-
tion tomaintain the energyﬂuxes at normal values (e.g. due to inhibition
of the respiratory complexes or in case of mitochondrial diseases), and
a third one (approx. 79% inmuscle and 21% in liver) cannot bemobilised
at all. These results are compatible with CoQ compartmentalisation,
although similar results with NADH oxidation were not provided in
order to functionally prove that the fraction of CoQ that is not utilisable
for succinate oxidation is channelled within supercomplex I–III.
Recently, it was demonstrated [47] that the physical assembly
between complexes I and III determines a preferential pathway for
electrons mediated by a dedicated subset of CoQ molecules. This
compartmentalisation prevents signiﬁcant cross talk between NADH
oxidation (Complex I-dependent) and succinate oxidation (dependent
on Complex II) or other ﬂavoenzyme-dependent oxidations.
Those Complex III molecules that physically interact with Complex I
in the formation of supercomplexes are also exclusively dedicated to
NADH oxidation (CIIINADH) while those Complex III molecules that are
not bound to Complex I are mainly responsible for oxidation of succi-
nate and other substrates using the free CoQ pool. Complex I has a
very high afﬁnity for Complex III, so that this association is preferred
to the free state of either Complex I or Complex III when a partial loss
of Complex III occurs. In this situation NADH oxidation is preferentially
maintained despite the risk of compromising the oxidation of FAD-
linked substrates [47].
3.1.3. Fixed assemblies: stoichiometric behaviour
Early experiments reported by Ragan and Heron [48] provided evi-
dence that puriﬁed Complex I and Complex III, when mixed as concen-
trated solutions in detergent and then co-dialysed, combine reversibly
in a 1:1 molar ratio to form a Complex I–III unit (NADH-cytochrome c
oxidoreductase) that contains equimolar FMN and cytochrome c1
(clearly at difference with the supercomplexes found by BN-PAGE,
where Complex III is present as a dimer) and 2–3 moles of CoQ10 per
mol of protein unit. The same authors also indicated that electron trans-
fer between a unit of Complex I–Complex III and any extra molecules of
Complexes I or III does not contribute to the overall rate of cytochrome c
reduction. The reduction by NADH of the cytochrome b of mixtures
of Complexes I and III is biphasic and the extents of the fast and
slow phases of reduction are determined by the amount of Complex III
speciﬁcally associated with Complex I.
Activation-energy measurements for NADH-cytochrome c oxidore-
ductase activity showed that oxidoreduction of endogenous CoQ10 pro-
ceeds somewhat differently from the oxidation and the reduction of
exogenous quinone homologues, supporting the idea that the mobility
of CoQ10 in the Complex I–III unit is highly restricted.
These studies were able for the ﬁrst time to demonstrate the exis-
tence of a supercomplex formed by Complexes I and III, although itsformation in vitro requires a speciﬁc low-lipid environment that appar-
ently may sound incompatible with the presence of phospholipids in
the natural inner mitochondrial membrane. Nevertheless, it is worth
mentioning that inner-outer membrane contacts and the quasi-solid
organisation of the matrix [49,50] may keep the integral proteins in a
clustered immobilised arrangement thus favouring segregation of
most of the phospholipids into separated patches.
These studies were able for the ﬁrst time to demonstrate the exis-
tence of a supercomplex formed by Complexes I and III, although its
formation in vitro requires a speciﬁc low-lipid environment.
3.1.4. Dissociation of supercomplexes shifts channelling to a less efﬁcient
pool behaviour
The previously described study [48] ﬁrst described stoichiometric
behaviour for the activity of NADH cytochrome c reductase, ascribable
to the formation of a supercomplex. However, CoQ-pool behaviour
could be restored and Complex I and Complex III could be made to
operate independently of each other by raising the concentrations
of phospholipid and ubiquinone (approx. a 2-fold and a 6-fold in-
crease, respectively) in the concentrated mixture [48] to levels com-
parable to those of natural mitochondrial membranes. Inclusion
of phospholipid into the reconstituted system may have a number
of effects on the physical state of the system. Heron and co-workers
have proposed that, when phospholipid in excess of that needed to
form an annulus is absent, relative mobility is lost and complexes
are frozen in their Complex I–III assembly favouring a stable orienta-
tion of the site of reduction of ubiquinone with respect to the site of
oxidation.
Heron et al. [51] also reported that endogenous CoQ10 leaks out of
the Complex I–III unit when extra phospholipid is present, causing a de-
crease in activity that could be alleviated by adding more ubiquinone.
It is likely that the function of the large amount of ubiquinone in the
natural membrane may be, therefore, to maintain the CoQ10 content
in the supercomplex unit when it is formed.
As a conclusion of these studies, Heron et al. [51] proposed a model
by which electron transfer occurs only through stoichiometric Complex
I–Complex III units, which, however, are formed and re-formed at rates
higher than the rate of electron transfer. This model would explain the
adherence to CoQ-pool behaviour of the activity in native membranes
(but see Section 3.1.1 for the criticisms to pool behaviour observations
in NADH oxidation).
Amore direct comparison of the effect of channellingwith respect to
CoQ-pool behaviour was performed in a simpler experimental condi-
tion in our laboratory.
A system, obtained by fusing a crude mitochondrial fraction (R4B)
[52] enriched in Complex I and Complex III with different amounts of
phospholipids and CoQ10 [53] was used in our laboratory to discrimi-
nate whether the reconstituted protein fraction behaves as individual
enzymes (CoQ-pool behaviour) or as assembled supercomplexes de-
pending on the experimental distances between the intramembrane
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cytochrome c reductase activity with the values expected by theoretical
calculation applying the pool equation (Eq. (2) in Section 3.1.1) showed
overlapping results at phospholipid dilutions (w/w) from 1:10 on,
i.e. for theoretical distances N50 nm. On the contrary, pool behaviour
was not effective and the observed rates of NADH-cytochrome c re-
ductase activity were higher than the theoretical values [53–55] at
low protein:lipid dilution (1:1 w/w), resembling the mean nearest
neighbour distance between respiratory complexes in mitochondria
[56,57,42].
Moreoverwhen the sameproteoliposomes at 1:1 lipid:protein ratios
were treatedwith dodecylmaltoside to destroy the supercomplex orga-
nisation, the NADH cytochrome c reductase activity fell dramatically,
whereas both Complex I and Complex III individual activities were un-
changed [58]; an analogous behaviour was detected by treating bovine
heart mitochondria with the same detergent.
Additional evidence for channelling between complexes I and III
derives from the demonstration that selective decrease of Complex III
content under a given threshold induces a preferential deﬁciency in
the transfer of electrons between complexes II and III while the transfer
of electrons between Complex I and III remains unaltered [47].
These studies clearly demonstrate that electron transfer between
Complex I and Complex III can take place both by CoQ channellingwith-
in the I1III2 supercomplex and by the less efﬁcient collision-based pool
behaviour, depending on the experimental conditions.
Recently, evidence has been obtained that electron transfer may
occur in vivo in the absence of supercomplexes.
Maas et al. [59] have been able to express functional alternative
oxidase (AOX) in mammalian cells lacking complexes III and IV. Under
these conditions, Complex I is stable and works perfectly in combination
with AOX, which is able to oxidise ubiquinol supplanting the combined
role of Complex III, cytochrome c and Complex IV (reported by J.A.
Enriquez and G. Lenaz, submitted paper). This demonstrates in vivo that
Complex I-dependent respiration does not strictly require supercomplex
I–III formation.
In addition to that, further evidence exists that supercomplexes may
be physiologically dissociable units (see Section 3.6, Evidence for the
dynamic nature of supercomplexes).
3.2. Evidence for channelling in the CoQ region was ﬁrst obtained by ﬂux
control analysis
The assumption that supercomplex association has the major func-
tion of conferring a rate advantage by substrate channelling arose
together with their discovery [3]. Although the theoretical basis of
channelling was already established [60], the ﬁrst demonstration of re-
spiratory supercomplex association on a functional basis was achieved
in our laboratory some years later [54,61].We exploited the ﬂux control
analysis and the principle that the sum of the ﬂux control coefﬁcients of
the individual enzymes in an integrated pathway must equal 1 unless
these enzymes form supramolecular units and establish substrate
channelling. In the latter case, these enzymes would be all equally
rate-limiting and the sum of the control coefﬁcients would be higher
than 1 [60].
Using this principle and exploiting inhibitionwith speciﬁc inhibitors,
in bovine heart mitochondria we found that both Complex I and Com-
plex III have ﬂux control coefﬁcients approaching 1, suggesting that
they behave as a single enzymatic unit, so that electron transfer through
Coenzyme Q is accomplished by channelling between the two com-
plexes. This approach is similar to that previously applied by Boumans
et al. [62], who had found that CoQ does not follow pool behaviour in
yeast mitochondria unless they are treated with chaotropic agents.
In addition, from our ﬂux control analysis using cyanide inhibition
[61], Complex IV appears to be randomly distributed, or in other
words that a large excess of active enzyme exists in free form in the
pathway from NADH to oxygen.Surprisingly, very fewother studieswere addressed to the functional
aspects of supercomplexes using metabolic control analysis [63–65];
these studies conﬁrmed that the respiratory chain, at least under certain
conditions, is organised in functionally relevant supramolecular struc-
tures. Quarato et al. [63] in digitonin-permeabilised HepG2 cells ob-
served that under conditions of high membrane potential the sum of
the ﬂux control coefﬁcients calculated for Complexes I, III and IV activi-
ties exceeded1, supporting the proposition that they are complexed in a
supramolecular unit (see Section 3.6.3 for further speculation on the
role of membrane potential).
In saponin-permeabilised breast and cholorectal tumor samples
Kaambre et al. [64,65] observed ﬂux control coefﬁcients for mitochon-
drial oxidative phosphorylation activities whose sum approached 4, in
contrast with lower values for normal tissues; they also interpret the
data as due to the presence of supercomplex association.
3.3. Complex II and other CoQ-reducing enzymes use the CoQ pool
The CoQ pool is certainly required for electron transfer from
Complex II to Complex III: in bovine heart mitochondria and submito-
chondrial particles, Complex II kinetically follows pool behaviour in
reconstitution experiments [66] and also in intact mitochondria [40];
this is in complete accordance with the lack of Complex II-containing
supercomplexes as found by both BN-PAGE [25]. Flux control analysis
[61] conﬁrmed that Complex II is the only rate-limiting step in succinate
oxidation, and both Complex III and Complex IV have low ﬂux control
coefﬁcients at difference with NADH oxidation (Section 3.2). The
existence of small amounts of supercomplexes including Complex II
molecules, described by Acín-Pérez et al. [27] in mouse cell lines and
in mouse liver mitochondria, does not contradict the knowledge
that most of succinate oxidation takes place by the CoQ pool between
Complexes II and III. An exception is the study of Boumans et al. [62]
in yeast, showing that succinate oxidation did not obey pool behaviour
unless the mitochondria were treated with chaotropic agents.
The CoQ pool behaviour must fully apply to other enzymes that de-
liver electrons to CoQ (succinate dehydrogenase, glycerol-3-phosphate
dehydrogenase, electron transfer ﬂavoprotein (ETF)-ubiquinone oxido-
reductase, dihydroorotate dehydrogenase, choline dehydrogenase,
sulﬁde CoQ reductase and proline dehydrogenase). These enzymes are
likely to be in minor amounts and strongly rate-limiting in integrated
electron transfer [67]. Few direct studies are however available on
possible associations of these enzymes. The only direct study addressed
to this problem [68] demonstrated that in brown fat mitochondria the
inhibition curve of glycerol phosphate-cytochrome c reductase is
sigmoidal in the presence of myxothiazol and antimycin, suggesting
the presence of a homogeneous CoQ pool between glycerol phosphate
dehydrogenase and Complex III.
Also the hyperbolic relation experimentally found by Gutman [31]
between succinate oxidase and the rate of reverse electron transfer
from succinate to NAD+, involving sequential interaction of complexes
II and I by means of CoQ, is in complete accordance with the pool equa-
tion. This observation poses a particularly puzzling question [6] about
how ubiquinol reduced by Complex II interacts from the pool with
the CoQ site in Complex I, since Complex I is totally engaged in the
supercomplex. The same dilemma applies to the NADH fumarate reduc-
tase activity that also involves interaction of Complex I and Complex II
(Section 3.1.2). In view of the recent progress in the knowledge of the
detailed atomic structure of Complex I [69,70], the previous view that
two different routes may exist for forward and reverse electron transfer
within Complex I [71] is no longer tenable as such, unless we consider
two different conformations, of which the one present during reverse
electron transfer makes the CoQ site more accessible to the pool.
It must be noted that the ATP-driven reverse electron transfer from
succinate to NAD+ occurs in the presence of a highmitochondrial trans-
membrane protonmotive force that, according to Piccoli et al. [72],
might be the physiological signal causing the structural reorganisation
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I–III supercomplex would dissociate its constituting complexes under
high ΔμH+ condition, and this would no longer limit the access from
the CoQ pool to the binding site in Complex I (cf Section 3.6.3). This
model is however incompatible with the observation reported by
Gutman [31] that NADH fumarate reductase, that occurs at low mem-
brane potential, shares the same pathway of the reverse reduction of
NAD+ by succinate (Section 3.1.2). According to this consideration,
the scheme in Fig. 2 shows that the pathways linking Complex II and
Complex I during either direct or reverse electron transfer most prob-
ably require the interaction of the CoQ pool with Complex I within the
supercomplex. If this is true, we must conclude that Complex I in the
supercomplex is somewhat accessible to the CoQ pool.
3.4. Saturation kinetics of Coenzyme Q
A ﬁnding that in the past was believed to strengthen the validity
of the random diffusion model is the observed saturation kinetics
of CoQ not only in succinate oxidation but also in NADH oxidation.
As previously described, Complex I is almost totally associated in a
supercomplex with Complex III, with electron channelling of bound
CoQ in the boundary between the two complexes, while the CoQ pool
is directly required for electron transfer from Complex II to Complex III.
The ﬁnding that Complex I is almost totally associated in a
supercomplex with Complex III seems to exclude a role for the CoQ
pool in physiological electron transfer between these two complexes.
Surprisingly, strong evidence exists that NADH cytochrome c reductase
activity follows saturation kinetics with respect to CoQ.
The relation between electron transfer rate and CoQ concentration
was seen for NADH and succinate oxidation in reconstituted systems
[66] and in phospholipid-enriched mitochondria [73]. Direct titrations
of CoQ-depleted mitochondria reconstituted with different CoQ
supplements yielded a “Km” of NADH oxidation for Qt in the range of
2–5 nmol/mgmitochondrial protein [66], corresponding to aQt concen-
tration of 4–10 mM in the lipid bilayer. The Km for CoQ10 of NADH-
cytochrome c reductase was found to be much higher than that of
succinate-cytochrome c reductase. A direct study on a reconstituted
mitochondrial fraction containing Complexes I and III showed that the
experimental rate of NADH cytochrome c reductase was hypercolically
related to the content of CoQ10, with an apparent Km in the same
range as in mitochondria [53].
Analysis of the literature shows that the physiological CoQ content of
several types of mitochondria is in the range of the Km for NADH oxida-
tion, and therefore not saturating for this activity [74]. However, this
does not exclude that free CoQ in the pool is also necessary for proper
channelling between the Complexes. In fact, the bound inter-complex
quinone that allows electron ﬂow directly from Complex I to Complex
III must be in dissociation equilibrium with the CoQ pool, so that
its amount, at steady state, would be dictated by the size of the pool:
this equilibrium explains the saturation kinetics for total ubiquinone
exhibited by the integrated activity of Complex I and Complex III and
the decrease of respiratory activities in mitochondria fused with phos-
pholipids with subsequent dilution of the CoQ pool. To be in agreement
with the experimental observation obtained by metabolic ﬂux analysis,
this proposition requires that the dissociation rate constants (koff)
of bound CoQ be considerably slower than the rates of inter-complex
electron transfer via the same bound quinone molecules [9,10]. The
high apparent Km for CoQ10 in NADH oxidation is in line with this pos-
tulation. The observation by Schneider et al. that dilution of the inner
membrane proteins with phospholipids lowers electron transfer and
the effect is reversed by CoQ addition is also in line with this concept
[73]. Earlier studies by Heron et al. also reported that endogenous
ubiquinone-10 leaks out of the Complex I–III unit when extra phospho-
lipid is present, causing a decrease in activity that could be alleviated by
adding more ubiquinone [51]. It is likely that the function of the large
amount of ubiquinone in the natural membrane may be, therefore, tomaintain the ubiquinone-10 content in the supercomplex unit when it
is formed.
The existence of I–III super-complexes where only inter-complex
bound CoQ is active by channelling electrons from Complex I to
Complex III is apparently incompatible with a dose-dependent effect
of exogenously administered CoQ10 as in several clinical studies [10];
however the notion that inter-complex bound CoQ is in chemical equi-
librium with CoQ in the pool is sufﬁcient to explain the improved cell
bioenergetics upon addition of exogenous CoQ. It is expected that
even a slight decrease of CoQ content in the membrane is sufﬁcient to
dissociate part of the quinone from the supercomplex thus decreasing
the rate of electron channelling.
3.5. Electron transfer through cytochrome c
The ﬂux control studies in our laboratory clearly established that CI
and CIII behave as a functional supercomplex in bovine heart and rat
liver mitochondria, whereas Complex IV does not since it has a low
ﬂux control coefﬁcient, despite the BN-PAGE showing that a fraction
of Complex IV is physically associated in the respirasome in the same
mitochondrial samples [61,55,67].
The reason for this discrepancy is not clear. It is true that most of CIV
appears to be free in the BN-gels (cf. Section 2), and onemight consider
that the activity in the respirasome ismasked by the excess of active en-
zyme in free form; however, the problem is rather difﬁcult to examine
critically. In fact, the experiments of Bianchi et al. [61] show that
NADH oxidase activity responds to cyanide inhibition with a lower
slope than cytochrome c oxidase. Assuming that (i) all CIV units, either
free or bound in the respirasome, have the same sensitivity to CN− and
that (ii) the probability of the inhibitor to bind the enzyme is the same
in both assay conditions, then the percent decrease of activity would be
the same for NADH oxidase and for cytochrome c oxidase if electron
transfer occurred by cytochrome c channelling in the respirasome,
giving a ﬂux control coefﬁcient close to unity. Since this is not the
case, we must conclude that either CIV in the supercomplex has a
lower sensitivity to cyanide or that cytochrome c can escape from the
respirasome and rely on an excess of free CIV units which can be ran-
domly reduced. The latter means that the free molecules of CIV are in-
volved in electron transfer from NADH, and implies that the molecules
in the supercomplex do not receive electrons from CIII by channelling
of cytochrome c [10]. Of course, we are aware that branched pathways
are difﬁcult to approach by metabolic control analysis and that mea-
surements in isolatedmitochondria by inhibitor titration of the relevant
enzymes inevitably involves using assay conditions (i.e. substrate
concentrations) that are not necessarily intended to reproduce in vivo
conditions.
Moreover, the non-artifactual nature of the lack of functional
channelling shown by the ﬂux control coefﬁcients in mammalianmito-
chondria is supported by the fact that in potato tuber mitochondria we
clearly showed that theﬂux control coefﬁcients approach 1 for each one
of the three complexes (CI, CIII, CIV); in suchmitochondria therefore the
respirasome seems to be completely functional in channelling [67]. The
reason for the difference may be in a tighter binding of cytochrome c in
the respirasome. Likewise in S. cerevisiaemitochondria Boumans et al.
[62] found evidence for cytochrome c channelling; accordingly, single
particle cryo-electron microscopy revealed that the supercomplex
consisting of a III2IV2 unit (since there is no Complex I in this yeast
species) is arranged in such way that the distance between the binding
sites of cytochrome c, i.e. cytochrome c1 in CIII and subunit II of CIV
(containing the CuA), is considerably shorter than in bovine mitochon-
dria [75]. To further confuse the issue, it is also worth to note that
Trouillard et al. [76] recently demonstrated in yeast mitochondria that
the time-resolved oxidation of cytochrome c by CIV is a randomprocess
not involving substrate compartmentalisation.
The puriﬁed supercomplex I1III2IV1 obtained from bovine heart [29]





















Fig. 3. Postulated organization of the respiratory chains in mammalian mitochondria. In
(A) are represented respirasomes (I–III–IV) and free cytochrome c oxidase (IV)molecules;
electron transfer between CI and CIII always occurs by CoQ (Q) channelling, whereas
fast dissociation of cytochrome c (C) from CIII may also allow electron transfer by random
collisions of free cytochrome c with CIV, either free or bound in other respirasomes (cf.
Section 3.5). In (B) is a scheme of the possible function of the supercomplex formed by
CI and CIII; in this case it is postulated that free cytochrome c collides with uncomplexed
CIV units. In (C) is depicted the mechanism of electron transfer from succinate via free CII
and the CoQ pool. This model may also apply to other enzymes feeding electrons to the
CoQ pool (see text for details). In this case, the CoQ pool interacts with either free CIII or
CIII/CIV associations. The CIII units are shown as monomers for sake of simplicity.
Reproduced from Genova and Lenaz [10] with permission.
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deﬁnitively exclude that substrate channelling on this level occurs also
in mammalian mitochondria.
Using a different approach, Enriquez recently demonstrated that at
least part of Complex IV forms a functional supercomplexwith channel-
ling of cytochrome c [47]. In particular, they showed thatwhen Complex
IV is allowed to participate in supercomplexes by the presence of SCAF1,
a signiﬁcant proportion of Complex IV activity is not utilised by glucose
driving respiration. Moreover, they demonstrated in isolated livermito-
chondria that the assembling of Complex IV in supercomplexes deﬁnes
three types of Complex IV, one dedicated exclusively to receive elec-
trons from NADH oxidation (forming supercomplex I + III + IV),
another dedicated to receive electrons from FAD-dependent enzymes
(forming supercomplex III + IV) and a third major one that is in free
form and that is able to receive electrons from both NADH and FADH2
oxidation.
On the contrary, if Complex IV is maintained permanently detached
from supercomplexes by elimination of SCAF1, the maximum respira-
tion activity of intact cells under glucose-rich medium parallels the
maximum respiration activity obtained in the same cells by feeding
directly electrons to Complex IV. In this case, since all Complex IV is
in free form and electron transfer takes place via diffusion of the cyto-
chrome c pool, this experiment demonstrates that the cytochrome c
pool function is also very efﬁcient.
Fig. 3 schematically shows different types of supercomplexes and
the postulated different mechanisms of electron transfer.
3.6. Evidence for the dynamic nature of supercomplexes
WhenAcín-Pérez et al. [27] demonstrated that puriﬁed respirasomes
(i.e. supercomplex I1III2IV1) were able to respire in a Clark's electrode,
they also observed other types of associations, as I + III or III + IV,
which were formed regardless the presence of the third partner of the
respirasome, strongly suggesting that they can also be present in vivo.
Therefore they concluded that the variety of associations between respi-
ratory complexes was larger than the respirasome and that the free
complexes likely co-existwith supercomplexes. In this context they pro-
posed an integrated model, the plasticity model, for the organisation of
the mitochondrial electron transport chain. The previous opposed
models, solid vs. ﬂuid, would be two extreme allowed and functional
situations of a dynamic range of molecular associations between re-
spiratory complexes [27]. The stoichiometry of the complexes and
the variable stability of different free vs. associated structures under
different physiological conditionswould determine a variety of different
structural options. The plasticity model and the dynamics of mitochon-
drial supercomplexes are widely discussed by J.A. Enriquez in this spe-
cial issue.
A fundamental prediction of the plasticity model is that, in vivo, the
mitochondrial respiratory chain should be able to work both when
supercomplexes are present andwhen the formation of supercomplexes
is prevented. Indeed, several studies in vitro support the view that
electron transfer in the respiratory chain can occur in absence of
supercomplexes, as extensively described in Section 3.1.
The early studies of Hackenbrock in the 80s showed that the
intramembrane particles are randomly distributed in the plane of
the inner membrane where they diffuse with relatively high diffusion
coefﬁcients in the range of 10−10 cm2s−1 [77,1]. Those accurate studies
cannot be dismissed as artefacts, therefore they must be explained
within the frame of a dynamic equilibrium between supercomplexes
and randomly diffusing individual complexes. To this respect, the time
window of the experimental approaches is of paramount importance
and must be taken in account.
The ﬁrst attempt to follow the temporal dynamics of the respiratory
complexes in situ was made by Muster et al. [78] who suggested that
supercomplex dissociation into a fully random distribution may not be
a fast event.In a very recent studyWilkens et al. [79] studied the impact of mito-
chondrial fusion/ﬁssion on the reorganisation of oxidative phosphoryla-
tion (OXPHOS) complexes in the inner mitochondrial membrane
of different HeLa cells tagged with ﬂuorescent proteins (GFP and
DsRed-HA). After cell fusion by polyethylene glycol treatment, redistri-
bution of the tagged OXPHOS complexes was followed by means of
immunoelectron microscopy, two color super-resolution ﬂuorescence
microscopy and single molecule tracking. In contrast to outer mem-
brane and matrix proteins, which mix quickly and homogeneously
upon mitochondrial fusion, the mixing of inner membrane proteins
was decelerated. The authors suggest that the composition of the cristae
is highly preserved during fusion of mitochondria and that cristae
with mixed OXPHOS complexes are slowly and successively formed
by restricted diffusion of the inner membrane proteins into the existing
cristae. Signiﬁcantly, Complex II was found very mobile, showing the
highest abundance in close proximity to the cristae junction (CJ) and a
signiﬁcant quota of molecules also localised in the inner boundary
membrane facing the outer mitochondrial membrane. On the contrary,
the diffusion of the other complexes was more restricted along the
intruding cristae membrane microcompartment distal from the CJ. In
particular, the comparison of the localisation proﬁles of OXPHOS com-
plexes I, III and IV in the innermembrane compartments clearly showed
an overlap: 80% of CI coincidedwith 80% of CIII and CIV, thus supporting
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estingly the diffusion coefﬁcients reported by Wilkens et al. [79] are of
the order of those reported by Hackenbrock et al. [1].
Someother observations in the literature indirectly support the view
that the supercomplex organisationmay not be ﬁxed but in equilibrium
with randomly dispersed complexes in living cells under physiological
conditions. Besides phospholipid composition that may change by
genetic or dietary reasons in a relatively long time-scale, somebiochem-
ical parameters at a shorter time-scale have been suggested to affect
the supramolecular structure of the respiratory complexes. These
parameters are the mitochondrial membrane potential and the phos-
phorylation state of the protein subunits of the complexes.
3.6.1. Lipid content and composition affect supercomplex association
Lipids are essential determinants of supercomplex association [6],
however they can modify the nature and extent of the associations
only in long time-scales, since they are affected by the organism species,
by the tissue, and within a given tissue and species by diet and lifestyle.
We will only brieﬂy summarise the inﬂuence that lipids have on
supercomplexes, since this subject is partly covered by G. Paradies in
this special issue.
The forces responsible for supercomplex association appear to
strongly depend on the lipid content and composition and likely on
the shape of the inner mitochondrial membrane [6]; in particular the
studies reported in Section 3.1.3 by Ragan [48,51] and from our labora-
tory [55] have shown that reconstitution of a binary I/III mitochondrial
protein fraction at a high lipid to protein ratio (N10:1) prevents forma-
tion of the I–III supercomplex, as shown by BN-PAGE and kinetic studies
[55]. In other words, it appears that dilution of the proteins with an
excess of phospholipids may weaken the forces holding together the
respiratory complexes.
Among lipids, cardiolipin and phosphatidyl ethanolamine are crucial
for mitochondrial functions; they are both non-bilayer-forming phos-
pholipids, due to their small polar heads compared with the bulky
nonpolar tails tails [80,81]. The phospholipids in closest vicinity to the
protein surface, as well as those in the free bilayer, are highly mobile
and free to exchange, but cardiolipin is tightly bound being more likely
buriedwithin the protein complexes [82–84]. The absolute requirement
of cardiolipin for the activity of cytochrome c oxidase, Complex I and
Complex III suggests that this phospholipid plays a crucial role in the
coupled electron transfer process [85,86].
There are now extensive indications that cardiolipin stabilises respi-
ratory supercomplexes as well as the individual complexes. Preliminary
results from our laboratory suggest that reconstitution of binary I/III
proteoliposomes (see above) at high lipid to protein ratio albeit
enriched with 20% cardiolipin (w:w), resembling the percent content
of cardiolipin in the mitochondrial membrane, can restore efﬁcient
NADH-cytochrome c reductase activity, which is presumably achieved
by preservation of CoQ10 channelling in the preparation [M. Kopuz
and Y. Birinci, unpublished data].
More evidence concerning this subject has been collected for the
III2–IV2 supercomplex in yeast mutants lacking cardiolipin [87,88]. The
putative direct protein–protein interaction of cytochrome c oxidase
and Complex III in yeast is proposed to involve also one molecule of
cardiolipin and one of phosphatidylethanolamine, tightly bound in a
cavity of the membrane imbedded domain of Complex III [83]. It
has been suggested that these two phospholipids can provide a ﬂexible
linkage between the interacting subunits of Complexes III and IV aswell
as with the ADP/ATP carrier that is also known to exist in physical asso-
ciation with the III–IV supercomplex [89]. Site-directedmutagenesis in-
vestigations [90] indicated that cardiolipin stabilises supercomplex
formation by neutralising the charges of lysine residues in the interac-
tion domain of Complex III with cytochrome c oxidase.
In addition the stability and assembly of Complex IV was found
to be reduced in yeast cells lacking Taz1 [91], the orthologous of
human tafazzin, an acyl transferase involved in the synthesis of maturetetralinoleyl cardiolipin [92]: mutations of tafazzin in humans result
in Barth syndrome, a cardio-skeletal myopathy with neutropenia,
characterised by respiratory chain dysfunction. Signiﬁcantly, the
cardiolipin defect in Barth syndrome results in destabilisation of the
supercomplexes by weakening the interactions between respiratory
complexes [93]. More recently, Gonzalvez et al. [94] conﬁrmed that in
immortalised lymphoblasts from Barth's syndromepatients the amount
of supercomplexes is decreased, as well as the amount of individual
complexes I and IV; these changes were compensated by increasing
mitochondrial mass.
It is well documented that exposure of mitochondria to reactive
oxygen species (ROS) can affect the respiratory activity via oxidative
damage of cardiolipin, which is required for the optimal functioning of
the enzyme complexes [95–97], reviewed by Paradies et al. [98]. Genova
et al. [55] demonstrated byﬂux control analysis that themaintenance of
a I–III supercomplex in proteoliposomes is abolished if lipid peroxida-
tion is induced by 2,2′-azobis-(2-amidinopropane) dihydrochloride be-
fore reconstitution. Evidently, the distortion of the lipid bilayer induced
by peroxidation and the alteration of the tightly bound phospholipids
determine dissociation of the supercomplex originally present in the
preparation.
In contrast with cardiolipin depletion that destabilises supercom-
plexes, a recent study reported that phosphatidyl ethanolamine deple-
tion tends to favour the formation of larger supercomplexes between
CIII and CIV in S. cerevisiae mitochondria [99]. The reason why
cardiolipin and phosphatidyletanolamine, both non-bilayer forming
phospholipids, behave in an opposite way on supercomplex stability
has been ascribed to the different charge, being the former an anionic
phospholipids and the latter zwitterionic [99].
3.6.2. Protein factors affecting supercomplex association
Besides the several assembly factors that have been described to be
required for the biogenesis and assembly of the supercomplexes (see
review by Enriquez in this special issue), up to now only a single protein
has been recently described that may be involved in the reversible
regulation of supercomplex association and activity: Hatle et al. [100]
identiﬁed MCJ/DnaJC15 as a distinct cochaperone that localises at the
mitochondrial inner membrane, where it interacts preferentially with
Complex I. MCJ impairs the formation of supercomplexes and functions
as a negative regulator of the respiratory chain. Knocking out the ex-
pression of MCJ leads to increased Complex I activity, mitochondrial
hyperpolarisation, and enhanced ATP production, in line with an
enhanced association of respiratory Complex I into supercomplexes. In
this study Hatle et al. [100] speculate that MCJ may be involved in the
balance between Complex I active and inactive forms; in addition MCJ
decreases Complex I activity by dissociating the supercomplexes.
3.6.3. Membrane potential
A study of the inﬂuence of the mitochondrial trans-membrane po-
tential (ΔμH+) on the ﬂux control exerted by cytochrome c oxidase
on the respiratory indicated that, under conditions mimicking state 4
respiration in intact cells and isolated mitochondria, the control
strength of the oxidase is decreased in respect to endogenous state 3
respiration [72]. More recently the extension of these studies to the
other proton-translocating respiratory complexes (I and III) revealed
that under conditions of low potential the sum of the ﬂux control co-
efﬁcients exceeded 1, whereas at high potential the coefﬁcients were
much lower [63].
Although the interpretation of the results in such a complex system
is very difﬁcult, the authors suggest that such a change in control
strength might be featured in terms of supercomplex plasticity. In par-
ticular, the results showing that the sum of the ﬂux control coefﬁcients
of Complexes I, III, and IV exceeds 1 in state 3, were compatible with
a respirasome organisation at lower membrane potential and with a
random organisation of cytochrome c oxidase with respect to other
complexes at high membrane potential (state 4); since the respiratory
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produce an extra advantage by raising the rate by channelling.
We extended the study in actively phosphorylating human hepato-
ma HepG2 cells under conditions in which the electrical (ΔΨ) and
chemical (ΔpH) components of ΔμH+ were selectively modulated by
addition of ionophores. We concluded that ΔΨ is predominantly
responsible for the tight control exerted by cytochrome c oxidase
over endogenous respiration whereas ΔpH seems irrelevant in this
respect [101].
Although the molecular mechanisms leading to the assembly/
disassembly of the supercomplexes have been not yet deﬁned, it is not
inconceivable that, given themembrane-integrated nature of the single
complexes, electrostatic/hydrophobic interactions may enter into play
in response to ΔμH+. In this respect, recent investigations have revealed
a surprising interplay between pH gradients, lipid composition and
packing and membrane cristae shape [102,103].
In potato tuber mitochondria it was found that hypoxia dissociates
the supercomplex I–III2–IV into individual Complex I plus Complex III–
IV units [104]; it was shown that the changewas due to the acidiﬁcation
of the medium in hypoxia and that acidiﬁcation could reproduce the
same effect of hypoxia; moreover the effect was not due to changes in
membrane potential.
3.6.4. Post-translational changes
It is now established that some of the mitochondrial complexes
are subjected to reversible phosphorylation and dephosphorylation
[105,106]. Mitochondria contain protein kinases and phosphatases
and both serine/threonine phosphorylation [107,108] and tyrosine
phosphorylation [107,109] of mitochondrial proteins are important in
regulation of activity of these organelles.
Phosphorylation of Complex I has been shown tomodify the activity
of the enzyme and its ROS generating capacity [110–114]. Cyclic
AMP-dependent phosphorylation of the 18 kDa subunit of Complex I,
encoded by the nuclear NDUFS4 gene, is required for import of the
subunit; modulation of subunit phosphorylation by intramitochondrial
protein kinase A and phosphoprotein phosphatase contributes to the
stability of Complex I and stimulation of its activity [115]. It is tempting
to speculate that the increase of activity of Complex I and thedecrease of
ROS generation by phosphorylation may be, in part, the result of en-
hanced stability of the I–III supercomplex, however no studies to date
have established any correlation between them. Phosphorylation of
Complex III subunits has also been reported although its functional
role remains undetermined [116].
Complex IV is a target of the intra-mitochondrial cAMP-PKA signal-
ling pathway [117,118].
It is tempting to speculate that endocrine alterations may affect the
assembly state of Complex IV, by hyper- or hypo-phosphorylation of
some subunits in the complex [10, J.A. Enriquez and G. Lenaz submitted
paper]. Indeed, cAMP- and PKA-dependent phosphorylation of Complex
IV in heartmitochondria [119]was found to be higher in free Complex IV
not associated in supercomplex than in the bound enzyme, suggesting
that phosphorylation prevents supercomplex association. Nevertheless,
caution must be exerted in the interpretation of the role of post-
translational changes in supercomplex formation, since no causal corre-
lation has yet been established.
3.7. Mechanism of electron transfer in the supercomplexes
Themechanism of electron transfer in supercomplexes is still uncer-
tain. Ideally, we should have a detailed knowledge of the molecular
structure of the interacting sites, and this knowledge is still lacking.
Obviously we may have the extremes from close docking of the active
sites with real interprotein tunnelling, up to relatively long distances
that may be covered either by important conformation changes or by
restricted diffusion (microdiffusion) of the mobile components within
the space between the two active sites; all of these alternatives havein common obligate channelling between two ﬁxed sites, so that even
the last situation, microdiffusion, would be quite distinguishable from
pool behaviour. In the latter case, the interaction of the mobile compo-
nent may stochastically occur with a great number of possible sites
located on several different protein targets which can be reached
by random diffusion [10]. In the interaction between Complex I and
Complex III within a supercomplex, if the sites are connected by CoQ
microdiffusion, it is possible that it takes place within a lipid milieu,
although we cannot exclude that the sites are put together by move-
ment of CoQ on the protein or by movement of the protein itself.
In the 3D structure of the mitochondrial supercomplex I1III2IV1
which was recently reported by Althoff et al., a unique arrangement of
the three component complexes indicates the pathways along which
ubiquinone and cytochrome c can travel to shuttle electrons between
their respective protein partners [29]. In the above mentioned model
(cf. also Section 3), one of the Complex III monomers faces the lipid bi-
layerwhile the other is surrounded by Complex I. Althoff and colleagues
also reported the presence of signiﬁcant amounts of bound phospho-
lipids in the puriﬁed respirasome from mammalian mitochondria and
estimated that roughly 300 lipid molecules would ﬁt the gap that ex-
tends between complexes I, III, and IV on the level of the membrane-
embedded portion of the supercomplex [29] (cf also Dudkina et al.
[120] and the article by N.V. Dudkina in this special issue).
There are recent indications that supercomplex association may
provide further kinetic advantages besides substrate channelling. The
study of Schaefer et al. [121] showed that a supercomplex comprising
cytochrome c oxidase (I1III2IV1) had higher Complex I and Complex III
activities than the supercomplex devoid of the terminal oxidase
(I1III2); evidently, the presence of Complex IV modiﬁes the conforma-
tion of the partner complexes in such a way to enhance their catalytic
activity. Likewise, Hildebrandt [122] showed that supercomplex disso-
ciation abolishes the protective effect of dehydroascorbic acid on sul-
phide toxicity to cytochrome c oxidase, suggesting a conformational
effect of supramolecular association on the allosteric properties of cyto-
chrome c oxidase.
Too little is known as yet about the possibility that protein–protein
interactions within the supercomplex I–III–IV might affect the subunits
that appear to be important in the proton-pumping mechanism of
Complex I, Complex III and Complex IV. The redox potential span
which provides the driving force for proton translocation across
the inner mitochondrial membrane is subjected to the steady state
reduction level of the electron donors/acceptors as catalyzed by the re-
spiratory supercomplex. It would be of interest to know whether the
supercomplex association may improve the proton pumping capability
of the respiratory chain by increasing the redox potential span of
the substrates that are channeled within the protein assembly itself,
in comparison to the homogenous donor/acceptor pool. However, to
our knowledge, a thermodynamic analyses that speciﬁcally addresses
this problem in the respiratory supercomplex is still lacking, possibly
because it is challenging to measure the redox potentials of the
ubiquinol/ubiquinone and ferro/ferricytochrome c couples directly in
the supercomplex.
4. Supercomplex association limits production of reactive oxygen
species from Complex I
The possibility that supercomplex assembly prevents excessive ROS
generation from Complex I has been advanced on theoretical grounds
[123–125] but in a complex biological system it is difﬁcult to ascertain
a clear relationship of cause to effect between supercomplex alteration
and ROS production, since each of the two phenomena may inﬂuence
the other one. On the contrary, in a recent study [58] we induced a pri-
mary condition in mitochondrial samples by which we could enhance
free Complex I with respect to Complex I bound to the supercomplex;
we obtained the ﬁrst direct demonstration that loss of supercomplex
organisation causes an enhancement of ROS generation by Complex I
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by Complex I in two experimental systems inwhich the supramolecular
organisation of the respiratory assemblies was destroyed by: (i) treat-
ment either of bovine heart mitochondria or liposome-reconstituted
supercomplex I–III with dodecyl maltoside; (ii) reconstitution of
Complexes I and III at high phospholipids to protein ratio (Fig. 4).
The ROS increase does not appear to be themere result of Complex I
damage as a possible consequence of the treatment in the presence of
detergents, since the NADH-ubiquinone redox activity is only slightly
depressed, though Complex I is mostly in its free form. Moreover, the
hypothetical reasoning that facilitation of electron ﬂow by substrate
channelling within the respirasome helps maintaining the redox com-
ponents of the complexes in the oxidised state, thus limiting ROS forma-
tion, cannot be the only explanation. In fact, in our study [58], ROS
production is investigated in the presence of inhibitors (mucidin and
rotenone) that prevent electron transfer to any possible acceptor,
so that we can guess that the redox centers in Complex I are maximally
reduced both in the situations where supercomplexes are maintained
and in the situation where Complex I is free.
Two potential sites for oxygen reduction exist in Complex I, repre-
sented by FMN [126] and iron–sulfur cluster N2 [127] or the (likely)
ubisemiquinone associated with this cluster [128], which might dis-
tinctly prevail in generating ROS under different conditions. N2 would
be a predominant source of ROS in membrane particles containing
super-assembled Complex I whereas FMN would become exposed
to oxygen only when Complex I is dissociated from Complex III [3].
Indeed, the actual shape of the I1III2IV1 supercomplex from bovine
heart [121] suggests a slightly different conformation of Complex I in
the supercomplex, showing a smaller angle of the matrix arm with the
membrane arm and a higher bending toward the membrane (and pre-
sumably Complex III) which may limit exposure of the redox centers
of Complex I to oxygen. On the contrary, the observed destabilisation
of Complex I in the absence of supercomplex may render the 51 kDa
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Fig. 4. Production of ROS by mitochondrial Complex I in different situations where
supercomplexes are maintained or disassembled. The percent value of ROS production is
plotted in the graph against the corresponding ratio of free Complex I versus total Complex
I. The statistical analysis of the data using the Pearson's parametric test indicates a positive
correlation (r = 0.884, p b 0.05) between ROS generation and relative amount of free
Complex I in the R4B proteoliposomes and in the SMP samples (black symbols). The
BHM samples (gray symbols) were not included in the correlation analysis because the
existence of endogenous antioxidant systems operating to reduce ROS levels in the mito-
chondria might have counteracted the dramatic effects of the complete dissociation of
Complex I, thus leading to a two-fold only increase of the measured ROS production.
SMP, submitochondrial particles. Figure reproduced from Maranzana et al. [58].This in vitro study is supported by several observations in cellular
and animal models linking together supercomplex dissociation and en-
hanced ROS production.
Inmouseﬁbroblasts expressing the activated formof the k-ras onco-
gene we had previously observed a strong decrease of high molecular
weight supercomplexes correlating with higher ROS generation in
comparison with wild type ﬁbroblasts [130,67]. Moreover, enhanced
ROS generation and oxidative stress were found in yeast mutants
lacking the supercomplex assembly factor Rcf1 and thus devoid of
supercomplexes III–IV [131–133]; since the yeast S. cerevisiae lacks
Complex I, in this case we may consider the origin of the extra ROS
being presumably free Complex III, while supposing that other potential
sources of ROS (i.e. external alternative NADH dehydrogenase) are not
affected in the Rcf1 mutants.
Numerous pathological states are accompanied by enhanced gener-
ation of ROS [134] and both mitochondria and other systems, such as
plasmamembrane NADPH oxidase, have been implicated as the sources
of ROS. In an experimentalmodel of heart failure, the decrease of oxida-
tive phosphorylation has been associated with a decrease of respiratory
supercomplexes [135,178,179].
Lymphoblasts from patients affected by Barth Syndrome, due to ge-
netic loss of tafazzin, an enzyme involved in cardiolipin remodelling,
have altered mitochondrial supercomplexes [93]; likewise, in a yeast
experimental model of tafazzin mutation, Chen et al. [136] observed
an increased oxidative stress in response to ethanol.
Aging is also accompanied by a decline of supercomplex association
[137,138]; despite some uncertainties and challenges, aging is generally
associated with increased ROS and oxidative damage (for a recent
review cf. Cui et al. [139]). Gómez and Hagen [140] reason that age-
associated destabilisation of respiratory supercomplexesmay be impor-
tant for the development of the mitochondrial aging phenotype
by means of impaired bioenergetics and enhanced ROS production; in
addition Frenzel et al. [138] on the basis of the 3D-structures of
supercomplexes and the close spatial arrangement of the respective
electron carrier binding sites [121] conclude that less superoxide radical
formation is expected to occur in supercomplexes than in randomly
distributed individual complexes. These latter studies, however, fail to
showwhich is the causing event (i.e. supercomplex dissociation causing
ROS increase or, alternatively, ROS increase causing supercomplex
dissociation) or even if they are independent phenomena.
5. Supercomplex association is required for the stability of Complex I
Since the discovery of supercomplexes it was noticed that the stabil-
ity of Complex I is strongly decreased when it is not assembled in the
respirasome.
The ﬁrst chromatographic isolation of a complete respirasome
(I1III4IV4) from digitonin-solubilised membranes of Paracoccus
denitriﬁcans indicated that Complex I is stabilised by assembly into
the NADH oxidase super-complex since attempts to isolate Complex
I from mutant strains lacking complexes III or IV led to the complete
dissociation of Complex I under the conditions of BN-PAGE. Reduced
stability of Complex I in those mutant strains was also apparent from
an almost complete loss of NADH CoQ reductase activity [26].
Analysis of the state of supercomplexes in human patients with an
isolated deﬁciency of Complex III [141,142] and in cultured cell models
harbouring Complex III [117], Complex IV [143] or cytochrome c [144]
depletion, lead to propose that the formation of respirasomes may be
essential for the assembly/stability of Complex I. Genetic alterations
leading to a loss of Complex III led to secondary loss of Complex I, there-
fore primary Complex III assembly deﬁciencies presented as Complex
III/I defects [117,145].
D'Aurelio et al. [146] studied the complementation of mitochondrial
DNA (mtDNA) in human cells by fusing two cell lines, one containing a
homoplasmic mutation in a subunit of respiratory chain Complex IV,
COX-I, and the other with a distinct homoplasmicmutation in a subunit
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ered in correlation with the presence of supercomplexes containing
complexes I, III and IV. From these ﬁndings, supercomplex assembly
was proposed as a necessary step for respiration (Fig. 5).
In a different study, deletion of the ndufs4 gene, encoding an acces-
sory subunit of Complex I, inmouse tissues results in decreased stability
and activity of Complex I: however, the portion of Complex I that is still
active is bound in the supercomplexes, indicating that the supramolec-
ular association improves the stability of Complex I [147].
Conversely, mutations of Complex I had controversial effects, since
in some studies they did not affect the amount of other complexes
[142,148], while in others they signiﬁcantly reduced the amounts
of Complexes III and IV [117,149–151]. The reason for this discrepancy
is not known, but might be related to the speciﬁcity of the mutation
affecting subunits of Complex I involved in the contacts with the other
complexes.
Animal models of the effects of Complex III and Complex IV muta-
tions on Complex I should prove useful for a better understanding of
the role of supercomplexes. In one study, knocked down predicted ho-
mologues of COX-IV and COX-Va in the nematode Caenorhabditis
elegans showed that intrinsic Complex I enzymatic activity is dependent
on the presence of Complex IV, despite no overall decrease in the
amount of Complex I [152]. In a further study in C. elegans the same
group showed that Complex III defects inhibit Complex I by several dif-
ferent mechanisms involving supercomplex destabilisation [153]. Mu-
tant analysis revealed that Complex III affects supercomplex I–III–IV
formation by acting as an assembly/stabilising factor. Also, a mtDNA
mutation affecting Complex III, ctb-1, inhibits Complex I function by
weakening the interaction of Complex IV in supercomplex I–III–IV.
Other Complex III mutations inhibit Complex I function either by de-
creasing the amount of Complex I (isp-1), or its assembly as the most
active supramolecular form, the I–III–IV supercomplex (isp-1;ctb-1).Fig. 5.Model of respiratory chain complexes structure and assembly inWT andmtDNAmutant
lecular structure (supercomplexes) composed of monomeric Complex I, dimeric Complex III a
partially assembled supercomplexes (III2 + IV) and individual complexes (dimeric Complex
supercomplexes, can exist in equilibrium with randomly organised, enzimatically active, isol
disassembly and degradation of Complex I; only Complex IV, mostly organised in a monome
the total loss of Complex IV results in a partial decrease of Complex I. The residual Complex I i
mutation. From thismodel, it is clear that Complex III constitutes the structural core towhichCo
of its instability, cannot exist as an individual complex. Reproduced from D'Aurelio et al. [146]It is suggested that allosteric interactions involve all three complexes
within the supercomplex and are necessary for maximal enzymatic
activities.
Is the stabilisation of Complex I by its association in a supercomplex
a primary effect on assembly during biogenesis or is it a secondary effect
on the stability of the Complex after its assembly? It is possible that both
events may occur.
Moreno-Lastres et al. [154] report that at early supercomplex assem-
bly stages Complex I is neither fully assembled nor active when it binds
to other respiratory chain complexes, since it lacks part of theN-module
catalytic subunits, thus suggesting that the supercomplex constitutes
the structural unit where Complex I gets to its complete assembly.
On the other hand, Acín-Peréz et al. [27,141] report that the assem-
bly of supercomplexes is temporally delayed from the full assembly
of the individual complexes and that association of Complex I and
Complex III is devoted to the storage and preservation of Complex I
since the enzyme stability and not its normal assembly is compromised
in the absence of Complex III.
Overall, we can suggest the following course of events:misassembled
CIII prevents formation of supercomplex; the lack of the supercomplex
association induces an enhanced ROS generation from Complex I
(see Section 4), with consequent Complex I damage: Complex I is
vulnerable to oxidative stress [155], and it was found that its activity
is strongly decreased by ROS through the peroxidation of cardiolipin
[156].
The fragility of free Complex I is not the result of inherent instability
of the enzyme, since the isolated Complex I is stable and active for long
time, as evidenced by the early studies of Hateﬁ and coworkers [15]
and also by our analysis of Complex I activity in proteoliposomes
[58]. However, Complex I shows some fragility due to its sensitivity to
the increased production of ROS during the activity of the respiratory
chain.cells. (A) InWTmammalian cells, respiratory chain complexes are organised in supramo-
nd mono-, di-, tri- or tetrameric Complex IV. The supercomplexes coexist with a pool of
III and monomeric Complex IV), indicating that a functional ‘solid-state’ model, like the
ated complexes. (B) In 100% CyB-MT cybrids, the complete loss of Complex III results in
ric form, remains in the mitochondrial inner membrane. (C) In 100% COX1-MT cybrids,
s completely assembled with Complex III; Complex III dimers are unaffected by the COX1
mplex I and Complex IV bind to forma stable supramolecular structure. Complex I, because
with permission.
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tein [157] suggests that the physical association of Complex I into
supercomplexes per se would explain all the above results. Thus it
points out to a different mechanism for Complex I destabilisation in
the absence of the Complexes III or IV, i.e. in an enhanced ROS genera-
tion (cf previous section) supporting the current knowledge that
Complex I is particularly sensitive to ROS damage.
Since ROS also damage lipids, and in particular cardiolipin, this
series of events can create a vicious circle of oxidative stress and
supercomplex disorganisation (Fig. 6) [3].
It is also noteworthy that some structural alterations of Complex III
are compatible with the supercomplex assembly but they can still in-
duce increased levels of ROS. Recently Ghelli et al. [158] characterised
the biochemical properties of cybrids carrying a human cytochrome b
missense mutation m.15579A N G, which substitutes the Tyr 278 with
Cys (p.278Y N C) that was identiﬁed in a patient with severe exercise
intolerance and multisystem manifestations. This mutation does not
induce disassembly of the supercomplex containing Complex I and
no subunit assembly defect of Complex III was reported in the mutant
cybrids. However, decreased amounts of dimeric Complex III, drastic
loss of its speciﬁc activity and enhanced ROS production were ob-
served with the mutated as compared to wild type cybrids. Evidently,
there must be speciﬁc structural consequences of Complex III muta-
tions in order to disassemble the I1III2IV supercomplex with conse-
quent destabilisation of Complex I. Similarities of the major ﬁndings
of the human mitochondrial model and its counterparts in bacteria
(Y302C Rhodobacter capsulatus) and in yeast (Y279C S. cerevisiae) are
remarkable [159], including decreased catalytic activity of Complex
III, enhanced ROS production and ensuing cellular responses and
damages.
6. Advantages of a dynamic superassembly in metabolic regulation
The supercomplex organisation of themitochondrial electron trans-
port chain may have deeper functional consequences than expected.
Rate changes that dependon the compartmentalisation of the respirato-
ry assembliesmay be expected to occur according to the substrate avail-
ability. These changes may address metabolic pathways to preferential
routes. Moreover, the possibility to modulate ROS production and ATP
levels by changing the supramolecular organisation may contribute to
the control of the cellular activity by interfering with redox-sensitive
and energy-sensitive signal transduction pathways.Fig. 6. Scheme showing how the loss of supercomplex organisationmay be involved in a vicious
consequence of supercomplex disassembling. Membrane phospholipid peroxidation and conse
stress, thus perpetuating the vicious circle. Depending on the amount produced, ROS can also6.1. Metabolic adaptations
According to Enriquez [47] the supercomplex organisation of
the respiratory chain by its dynamic character is able to optimise the
use of available substrates. Glucose utilisation as a fuel contributes
largely to feed electrons to the respiratory chain through NADH
and Complex I, and less through FAD-linked substrates (succinate,
glycerol-3-phosphate), whereas fatty acid oxidation feeds more elec-
trons through a FAD-linked pathway (ETF dehydrogenase). The major
difference between these two pathways is that NADH delivers electrons
through the respirasome, whereas FAD-linked oxidations use the
CoQ pool. Adjustment of respiratory superassembly would provide a
mechanism to ensure efﬁcient oxidation of available substrates. To
test this, Lapuente-Brun et al. [47] analyzed respiration capacity through
the FAD and NADH routes in liver mitochondria from CD1 and C57Bl/6J
mice fed ad libitum or fasted for 18 h to activate fatty acids degradation.
In CD1 mitochondria, fasting reduced maximal Complex I and Complex
I + III activities without inﬂuencing Complex II or Complex II + III, but
this effect was not seen in C57Bl/6J mitochondria. Accordingly, only in
CD1 mitochondria, the proportion of CIII assembled with CI (NADH
route) is reduced by fasting.
Adaptation to mitochondrial respiratory substrates that generate
different proportions of NADH and FADH2 (as when mitochondria rely
on fatty acids rather than glucose during fasting) requires adjustments
to the capacity for electron transport via the NADH and FAD routes.
Regulatedmodiﬁcation of the proportion of respiratory supercomplexes
allows this adaptation [47], but how this change is produced and what
would happen if this adaptation were impeded remain to be investi-
gated. At present no known molecular mechanism can be invoked
to explain the exquisite regulation of the balance between NADH/
Complex III (Complex III dedicated to Complex I) and FAD/Complex III.
Further understanding of this behaviour is of paramount importance.
Themodulation of supercomplex assembly may have further conse-
quences resulting from rate modulation in the respiratory chain. Disso-
ciation of supercomplexes would help keep NADH oxidation low and
hence a high NADH/NAD+ ratio within mitochondria. This may help
a metabolic switch towards biosynthetic pathways, e.g. by elevating
mitochondrial citrate levels and thus favouring citrate export and lipid
biosynthesis. At the same time the increased reducing power will also
favour biosynthetic pathways.
The possibility of organised multienzyme systems that may allow
NADH to be transferred directly from its partner dehydrogenase tocircle of oxidative stress and energy failure. ROS production by Complex I is enhanced as a
quent further loss of supercomplex organisationmay occur due tomitochondrial oxidative
operate as signalling molecules from mitochondria to the cell. See text for explanations.
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been observed that several mitochondrial soluble NAD+-dependent
dehydrogenases such asmalate dehydrogenase,β-hydroxyacyl-CoAde-
hydrogenase, α-ketoglutarate dehydrogenase complex, and the pyru-
vate dehydrogenase complex speciﬁcally associate with Complex I
[160–162]. However, evidence for an effective NADH oxidation mecha-
nism via substrate channelling, compared to free diffusion of the sub-
strate, remains controversial [163].
6.2. ROS modulation of signalling pathways
In addition to a means of modulating the oxidative phosphorylation
machinery, the plasticity of the respiratory chain supercomplexes
(cf. Section 3.6) can be envisaged as a possiblemechanism of intracellu-
lar signalling. In the latter case, the regulatory effect of the dynamic as-
sociation of supercomplexes over the production of ROS (cf. Section 5)
would be of great importance. In fact, ROS act as damaging agents and
also operate as signalling molecules from mitochondria to the cell,
depending on the amount produced [164–166].
Our understanding of the signalling pathwaysmodulated by ROShas
expanded in recent years, thus providing the answer to the apparent
paradox between the speciﬁcity that is required for signalling and
the reactive nature of ROS that renders them indiscriminate and poten-
tially lethal oxidants. Speciﬁcity in intracellular signalling is generally
achieved through the non-covalent binding of a ligand to its cognate
receptor by virtue of the complementarity of macromolecular shapes.
By contrast, ROS molecular recognition occurs at the atomic level and
they operate in signalling mainly through chemical reactions with spe-
ciﬁc sulfhydryl groups of target proteins involved in signal transduction
pathways [167]. These ROS signals are generally not primary agonists
but are superimposed co-signals thatmay allow the integration of cellu-
lar activities by recruiting, timing, and tuning growth-factor signalling
pathways in accordance with the metabolic state of the cell. The para-
digm of mitochondrial signalling leading to changes in nuclear gene
expression is relatively novel and is considered “mitochondrial retro-
grade signalling” [168]. The retrograde signalling pathway interacts
with several other signalling pathways, such as target of rapamycin
(TOR) and ceramide signalling. All of these pathways respond to stress,
includingmetabolic stress [169]. ROS can be part of an important retro-
grade signal by stimulating the antioxidant response element (ARE) of
cytoprotective genes. One notable example is Nrf2 that, in the presence
of ROS, is translocated from the cytoplasm to the nucleus. There, it binds
the ARE of genes involved in the antioxidant response like heme oxy-
genase and inducers of mitochondrial biogenesis such as NRF-1 [170].
A large body of data in the literature suggests that mitochondrial
biogenesis and re-shaping of the mitochondrial network are tuned
to accommodate the energy demand in tissues with variable metabolic
activity, or during development (for review, see [171]). Tasseva et al.
[172] recently reported of mitochondrial alterations that occur in a cell
model with moderate depletion of mtPE, as a result of RNAi silencing
of phosphatidylserine decarboxylase and the consequent diminished
biosynthesis of PE. The authors demonstrate that this cell condition
impairs the supramolecular organisation of CI and CIV in form of respi-
ratory supercomplexes. Interestingly, mitochondria are extensively
fragmented and their ultrastructure is grossly aberrant, despite normal
or even increased levels of mitochondrial fusion proteins in the mtPE-
deﬁcient cells and no reduction in mitochondrial membrane potential.
The results of Tasseva et al. [172] suggest a possible link between respi-
ratory chain supercomplexes, cell metabolism and mitochondrial mor-
phology. However, to gain further insight into this subject it has
become critical to decipher the stimuli, the pathways, and the physiolo-
gy behind mitochondrial adaptation. Benard et al. [173] showed that a
parallel increase in mitochondrial biogenesis and mitochondrial ﬁssion
occurs when the level of Complex IV inhibition reaches a sufﬁcient
(high) degree that initiates a drop in mitochondrial respiratory rate
[174]. This metabolic condition is obtained in human ﬁbroblasts grownin the presence of potassium cyanide in order to mimic an OXPHOS de-
fect, as in Benard's experimental model, but a similar condition occurs
when efﬁcient electron channelling within the supercomplexes is lost
(cf. previous sections). The retrograde activation of mitochondrial bio-
genesis observed by Benard et al. [173] upon cell energy deprivation
involves the increase in cytosolic NO concentration, as a consequence
of upregulated endothelial NO synthase (eNOS) by the cAMP response
element binding protein (CREB). This condition is blocked by inhibition
of NO production. While the downstream signalling pathway that con-
nects NO to mitochondrial biogenesis is already deciphered [175], the
molecular determinants linking the respiratory chain to CREB activation
remain poorly understood. However, it is worth noting that the group
of Arnould analyzed the mitochondria-to-nucleus communication in
cells grown in the presence of the respiratory chain Complex III inhibitor
antimycin A [176], or in conditions of mitochondrial protein synthesis
suppression [176], and of mitochondrial DNA depletion [177]. In all
cases, their studies revealed the activation of CREB consecutive to mito-
chondrial bioenergetic stress.
Mitochondrial dysfunction and deﬁciency of respiratory supercom-
plexes are correlated to mitochondrial morphology/quality mainte-
nance also in the development of the mitochondrial aging phenotype
[137,138,140] and in the etiopathology of several diseases, like
Parkinson's and Alzheimer's disease, cardiac dysfunction, diabetes and
cancer [93,178,179].
Much of the work dedicated to deciphering the mammalian retro-
grade response has utilised cancer cell lines reﬂecting the fact that the
mitochondrial defects have been associatedwithmany types of cancers.
Wallace provides an excellent review [180], outlining multiple exam-
ples of mitochondrial genetic and metabolic defects leading to altered
nuclear gene expression and tumorigenic progression.
MtDNA mutations in genes encoding Complex I subunits ND4, ND5
and ND6 have been found in various cancer cells [181]. In cell lines
carrying a heteroplasmic ND5 mutation similar to a natural ND5 mu-
tation found in colorectal cancer [182], Sharma and coll. [183] investi-
gated the role of Complex I in tumorigenesis and the effects of rescued
function of Complex I by introducing the gene of the yeast alternative
NADH:quinone oxidoreductase (NDI1) into cells. They found that, with
the restoration of respiration and mitochondrial functions, the tumori-
genic potential could be reversed. They also demonstrated that such
regulation is mediated by metabolic alterations (i.e. 32% decrease in
the NAD+/NADH ratio in Complex I defective cells compared with con-
trol) and by changes in ROS production that modulate the v-AKT mu-
rine thymoma viral oncogene (AKT) pathway during Complex I stress.
In Sharma's study, themutant cells exhibited increased oxidative stress
because of a genetic defect in Complex I, but there is no indication about
how exactly the respiratory chain is organised in the cells. However, el-
evated ROS levels and altered redox status are common characteristics
of many tumors; in some cases, a deep implication of the supercomplex
organisation of the respiratory chain was also suggested [184].
It is easy to foresee that speciﬁc metabolic signals may arise in the
cell in response to a tuned production of ROS from the mitochondrial
respiratory chain, as a consequence of the controlled dinamicity
of supercomplex assembling/disassembling [26] at different physio-
pathological conditions.
7. Concluding remarks
In the recent years our view of the mitochondrial OXPHOS system
has changed to a more integrated approach to mitochondrial structure
and function within the cell. This new understanding has opened unex-
pected perspectives particularly in relation to the role that mitochon-
dria exert both in cell physiology and in pathological changes. On one
side,mitochondria are recognised to be central in the pathways of intra-
cellular communication; on the other, the ﬁeld of mitochondrial medi-
cine is now growing exponentially, shedding light on the pathogenesis
of diseases in almost every branch of pathology. In this scenario, the
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position, in view of the multiple role that supercomplex association
exerts in mitochondria. Unfortunately, the structural evidence for
supercomplex association is not matched by a corresponding knowl-
edge of their function(s), and several questions are still open concerning
the functional role of such supramolecular entities. In this review we
have attempted to point out themajor ﬁndings related to the functional
role of respiratory supercomplexes. Although the overall picture is not
yet clear, what is emerging is a dynamic pattern opening fascinating
research avenues in the ﬁeld of metabolic control and regulation of sig-
nalling pathways.References
[1] C.R. Hackenbrock, B. Chazotte, S.S. Gupte, The random collisionmodel and a critical
assessment of diffusion and collision in mitochondrial electron transport,
J. Bioenerg. Biomembr. 18 (1986) 331–368.
[2] D.E. Green, A. Tzagoloff, The mitochondrial electron transfer chain, Arch. Biochem.
Biophys. 116 (1966) 293–304.
[3] H. Schägger, K. Pfeiffer, Supercomplexes in the respiratory chains of yeast and
mammalian mitochondria, EMBO J. 19 (2000) 1777–1783.
[4] H. Eubel, J. Heinemeyer, S. Sunderhaus, H.P. Braun, Respiratory chain supercomplexes
in plant mitochondria, Plant Physiol. Biochem. 42 (2004) 937–942.
[5] I.Wittig, R. Carrozzo, F.M. Santorelli, H. Schägger, Supercomplexes and subcomplexes
of mitochondrial oxidative phosphorylation, Biochim. Biophys. Acta 1757 (2006)
1066–1072.
[6] G. Lenaz, M.L. Genova, Kinetics of integrated electron transfer in the mitochondrial
respiratory chain: random collisions vs. solid state electron channeling, Am. J.
Physiol. Cell Physiol. 292 (2007) C1221–C1239.
[7] E.J. Boekema, H.P. Braun, Supramolecular structure of the mitochondrial oxidative
phosphorylation system, J. Biol. Chem. 282 (2007) 1–4.
[8] J. Vonck, E. Schäfer, Supramolecular organization of protein complexes in themito-
chondrial inner membrane, Biochim. Biophys. Acta 1793 (2009) 117–124.
[9] G. Lenaz, M.L. Genova, Structure and organization of mitochondrial respiratory
complexes: a new understanding of an old subject, Antioxid. Redox Signal. 12
(2010) 961–1008.
[10] M.L. Genova, G. Lenaz, New developments on the functions of coenzyme Q in
mitochondria, Biofactors 37 (2011) 330–354.
[11] M.L. Genova, G. Lenaz, A critical appraisal of the role of respiratory supercomplexes
in mitochondria, Biol. Chem. 394 (2013) 631–639.
[12] I. Wittig, H. Schägger, Features and applications of blue-native and clear-native
electrophoresis, Proteomics 8 (2008) 3974–3990.
[13] J.B. Bultema, H.P. Braun, E.J. Boekema, R. Kouril, Megacomplex organization of
the oxidative phosphorylation system by structural analysis of respiratory
supercomplexes from potato, Biochim. Biophys. Acta 1787 (2009) 60–67.
[14] Y. Hateﬁ, A.G. Haavik, P. Jurtshuck, Studies on the electron transfer system. XXX.
DPNH cytochrome c reductase I, Biochim. Biophys. Acta 52 (1961) 106–118.
[15] Y. Hateﬁ, A.G. Haavik, D.E. Grifﬁths, Studies on the electron transfer system. XL.
Preparation and properties of mitochondrial DPNH-Coenzyme Q reductase,
J. Biol. Chem. 237 (1962) 1676–1680.
[16] Y. Hateﬁ, A.G. Haavik, D.E. Grifﬁths, Studies on the electron transfer system. XLI.
Reduced Coenzyme Q (QH2)-cytochrome c reductase, J. Biol. Chem. 237 (1962)
1681–1685.
[17] A. Yu, L. Yu, T.E. King, Soluble cytochrome b–c1 complex and the reconstitution of
succinate-cytochrome c reductase, J. Biol. Chem. 249 (1974) 4905–4910.
[18] N.K. Boardman, Subchloroplast fragments: digitonin method, Methods Enzymol.
23 (1971) 268–276.
[19] R.A. Capaldi, Arrangement of proteins in the mitochondrial inner membrane,
Biochim. Biophys. Acta 694 (1982) 292–306.
[20] E.A. Berry, B.L. Trumpower, Isolation of ubiquinol oxidase from Paracoccus
denitriﬁcans and resolution into cytochrome bc1 and cytochrome c-aa3 complexes,
J. Biol. Chem. 260 (1985) 2458–2467.
[21] N. Sone, M. Sekimachi, E. Kutoh, Identiﬁcation and properties of a quinol oxidase
super-complex composed of a bc1 complex and cytochrome oxidase in the ther-
mophilic bacterium PS3, J. Biol. Chem. 262 (1987) 15386–15391.
[22] T. Iwasaki, K. Matsuura, T. Oshima, Resolution of the aerobic respiratory system of
the thermoacidophilic archaeon, Sulfolobus sp. strain 7. I. The archaeal terminal
oxidase supercomplex is a functional fusion of respiratory complexes III and IV
with no c-type cytochromes, J. Biol. Chem. 270 (1995) 30881–30892.
[23] T. Ozawa, M. Nishikimi, H. Suzuki, M. Tanaka, Y. Shimomura, Structure and assem-
bly of mitochondrial electron-transfer complexes, in: T. Ozawa, S. Papa (Eds.),
Bioenergetics: Structure and Function of Energy-Transducing Systems, Japan Sci.
Soc. Press, Tokyo, 1987, pp. 101–119.
[24] J. Hochman, S. Ferguson Miller, M. Schindler, Mobility in the mitochondrial elec-
tron transport chain, Biochemistry 24 (1985) 2509–2516.
[25] H. Schägger, K. Pfeiffer, The ratio of oxidative phosphorylation complexes I–V in bo-
vine heart mitochondria and the composition of respiratory chain supercomplexes,
J. Biol. Chem. 276 (2001) 37861–37867.
[26] A. Stroh, O. Anderka, K. Pfeiffer, T. Yagi, M. Finel, B. Ludwig, H. Schägger, Assembly
of respiratory complexes I, III, and IV into NADH oxidase supercomplex stabilizes
complex I in Paracoccus denitriﬁcans, J. Biol. Chem. 279 (2004) 5000–5007.[27] R. Acín-Pérez, P. Fernández-Silva, M.L. Peleato, A. Pérez-Martos, J.A. Enriquezm,
Respiratory active mitochondrial supercomplexes, Mol. Cell 32 (2008) 529–539.
[28] J. Ovàdi, Physiological signiﬁcance of metabolic channelling, J. Theor. Biol. 152
(1991) 135–141.
[29] T. Althoff, D.J. Mills, J.L. Popot, W. Kühlbrandt, Arrangement of electron transport
chain components in bovine mitochondrial supercomplex I1III2IV1, EMBO J. 30
(2011) 4652–4664.
[30] A. Kröger, M. Klingenberg, The kinetics of the redox reactions of ubiquinone related
to the electron-transport activity in the respiratory chain, Eur. J. Biochem. 34 (1973)
358–368.
[31] M. Gutman, Kinetic analysis of electron ﬂux through the quinones in the mito-
chondrial system, in: G. Lenaz (Ed.), Coenzyme Q, Wiley, Chichester, UK, 1985,
pp. 215–234.
[32] C.I. Ragan, I.R. Cottingham, The kinetics of quinone pools in electron transport,
Biochim. Biophys. Acta 811 (1985) 13–31.
[33] P.R. Rich, Electron and proton transfers through quinones and bc complexes,
Biochim. Biophys. Acta 768 (1984) 53–79.
[34] G. Lenaz, M.L. Genova, Mobility and function of Coenzyme Q (ubiquinone) in the
mitochondrial respiratory chain, Biochim. Biophys. Acta 1787 (2009) 563–573.
[35] A. Kröger, M. Klingenberg, Further evidence of the pool function of ubiquinone as
derived from the inhibition of the electron transport by antimycin, Eur. J. Biochem.
39 (1973) 313–323.
[36] R. Fato, E. Estornell, S. Di Bernardo, F. Pallotti, G. Parenti Castelli, G. Lenaz,
Steady-state kinetics of the reduction of coenzyme Q analogs by complex I
(NADH:ubiquinone oxidoreductase) in bovine heart mitochondria and submito-
chondrial particles, Biochemistry 35 (1996) 2705–2716.
[37] E. Estornell, R. Fato, F. Pallotti, G. Lenaz, Assay conditions for the mitochondrial
NADH:coenzyme Q oxidoreductase, FEBS Lett. 332 (1993) 127–131.
[38] M.L. Genova, C. Castelluccio, R. Fato, G. Parenti Castelli, M. Merlo Pich, G. Formiggini,
C. Bovina,M.Marchetti, G. Lenaz,Major changes in complex I activity inmitochondria
from aged rats may not be detected by direct assay of NADH:coenzyme Q reductase,
Biochem. J. 311 (1995) 105–109.
[39] H. Baum, Coupling between the charge-separating devices of the mitochondrion:
intra- or extramembrane, in: S. Fleischer, Y. Hateﬁ, D.H. MacLennan, A. Tzagoloff
(Eds.), Molecular Biology of Membranes, Plenum Press, New York, NY, 1977,
pp. 243–262.
[40] B. Stoner, Steady-state kinetics of the overall oxidative phosphorylation reaction
in heart mitochondria. Determination of the coupling relationships between the
respiratory reactions and miscellaneous observations concerning rate-limiting
steps, Bioenerg. Biomembr. 16 (1984) 115–141.
[41] R.J. Froud, C.I. Ragan, Cytochrome c-mediated electron transfer between
ubiquinol-cytochrome c reductase and cytochrome c oxidase. Kinetic evidence
for a mobile cytochrome c pool, Biochem. J. 217 (1984) 551–560.
[42] G. Lenaz, Role of mobility of redox components in the inner mitochondrial mem-
brane, J. Membr. Biol. 104 (1988) 193–209.
[43] S.S. Gupte, C.R. Hackenbrock, Multidimensional diffusion modes and collision
frequencies of cytochrome c with its redox partners, J. Biol. Chem. 263 (1988)
5241–5247.
[44] S.S. Gupte, C.R. Hackenbrock, The role of cytochrome c diffusion in mitochondrial
electron transport, J. Biol. Chem. 263 (1988) 5248–5253.
[45] S. Kawato, E. Sigel, E. Carafoli, R.J. Cherry, Rotation of cytochrome oxidase in phos-
pholipid vesicles. Investigations of interactions between cytochrome oxidases and
between cytochrome oxidase and cytochrome bc1 complex, J. Biol. Chem. 256
(1981) 7518–7527.
[46] G. Benard, B. Faustin, A. Galinier, C. Rocher, N. Bellance, K. Smolkova, L. Casteilla, R.
Rossignol, T. Letellier, Functional dynamic compartmentalization of respiratory
chain intermediate substrates: implications for the control of energy production
and mitochondrial diseases, Int. J. Biochem. Cell Biol. 40 (2008) 1543–1554.
[47] E. Lapuente-Brun, R. Moreno-Loshuertos, R. Acín-Peréz, A. Latorre-Pellicer, C. Colás,
E. Balsa, E. Perales-Clemente, P.M. Quirós, E. Calvo, M.A. Rodríguez-Hernández, P.
Navas, R. Cruz, Á. Carracedo, C. López-Otín, A. Pérez-Martos, P. Fernández-Silva,
E. Fernández-Vizarra, J.A. Enríquez, Supercomplex assembly determines electron
ﬂux in the mitochondrial electron transport chain, Science 340 (2013) 1567–1570.
[48] C.I. Ragan, C. Heron, The interactionbetweenmitochondrialNADH-ubiquinoneoxido-
reductase and ubiquinol-cytochrome c oxidoreductase—evidence for stoicheiometric
association, Biochem. J. 174 (1978) 783–790.
[49] P.A. Srere, The structure of the mitochondrial inner membrane-matrix compart-
ment, TIBS 7 (1982) 375–378.
[50] P.A. Srere, Complexes of sequential metabolic enzymes, Annu. Rev. Biochem. 56
(1987) 89–124.
[51] C. Heron, C.I. Ragan, B.L. Trumpower, The interaction between mitochondrial
NADH-ubiquinone oxidoreductase and ubiquinol-cytochrome c oxidoreductase—
restoration of ubiquinone-pool behaviour, Biochem. J. 174 (1978) 791–800.
[52] J.S. Rieske, Preparation and properties of reduced Coenzyme Q-cytochrome c
reductase (complex III of the respiratory chain), Methods Enzymol. 10 (1967)
239–245.
[53] G. Lenaz, R. Fato, S. Di Bernardo, D. Jarreta, A. Costa, M.L. Genova, G. Parenti Castelli,
Localization and mobility of coenzyme Q in lipid bilayers and membranes,
Biofactors 9 (1999) 87–93.
[54] C. Bianchi, R. Fato, M.L. Genova, G. Parenti Castelli, G. Lenaz, Structural and func-
tional organization of Complex I in the mitochondrial respiratory chain, Biofactors
18 (2003) 3–9.
[55] M.L. Genova, A. Baracca, A. Biondi, G. Casalena,M. Faccioli, A.I. Falasca, G. Formiggini,
G. Sgarbi, G. Solaini, G. Lenaz, Is supercomplex organization of the respiratory chain
required for optimal electron transfer activity? Biochim. Biophys. Acta 1777 (2008)
740–746.
441M.L. Genova, G. Lenaz / Biochimica et Biophysica Acta 1837 (2014) 427–443[56] G. Vanderkooi, Organization of protein and lipid components in membranes, in: S.
Fleischer, Y. Hateﬁ, D. MacLennan, A. Tzagoloff (Eds.), Molecular Biology of Mem-
branes, Plenum Publishing Corp., New York, NY, 1978, pp. 25–55.
[57] K. Schwerzmann, L.M. Cruz-Orive, R. Eggman, A. Sänger, E.R. Weibel, Molecular
architecture of the inner membrane of mitochondria from rat liver: a combined
biochemical and stereological study, J. Cell Biol. 102 (1986) 97–103.
[58] E. Maranzana, G. Barbero, A.I. Falasca, G. Lenaz, M.L. Genova, Mitochondrial respi-
ratory supercomplex association limits production of reactive oxygen species
from Complex I, Antioxid. Redox Signal. 19 (2013) 1469–1480.
[59] M.F.P.M. Maas, F. Krause, N.A. Dencher, A. Sainsard-Chanet, Respiratory complexes
III and IV are not essential for the assembly/stability of complex I in fungi, J. Mol.
Biol. 387 (2009) 259–269.
[60] N.B. Kholodenko, H.V. Westerhoff, Metabolic channelling and control of the ﬂux,
FEBS Lett. 320 (1993) 71–74.
[61] C. Bianchi, M.L. Genova, G. Parenti Castelli, G. Lenaz, The mitochondrial respiratory
chain is partially organized in a supercomplex assembly: kinetic evidence using
ﬂux control analysis, J. Biol. Chem. 279 (2004) 36562–36569.
[62] H. Boumans, L.A. Grivell, J.A. Berden, The respiratory chain in yeast behaves as a
single functional unit, J. Biol. Chem. 273 (1998) 4872–4877.
[63] G. Quarato, C. Piccoli, R. Scrima, N. Capitanio, Variation of ﬂux control coefﬁcient of
cytochrome c oxidase and of the other respiratory chain complexes at different
values of protonmotive force occurs by a threshold mechanism, Biochim. Biophys.
Acta 1807 (2011) 1114–1124.
[64] T. Kaambre, V. Chekulayev, I. Shevchuk, M. Karu-Varikmaa, N. Timohhina, K. Tepp,
J. Bogovskaja, R. Kütner, V. Valvere, V. Saks, Metabolic control analysis of cellular
respiration in situ in intraoperational samples of human breast cancer, J. Bioenerg.
Biomembr. 44 (2012) 539–558.
[65] T. Kaambre, V. Chekulayev, I. Shevchuk, K. Tepp, N. Timohhina, M. Varikmaa, R.
Bagur, A. Klepinin, T. Anmann, A. Koit, A. Kaldma, R. Guzun, V. Valvere, V. Saks,
Metabolic control analysis of respiration in human cancer tissue, Front. Physiol. 4
(2013) 151.
[66] E. Estornell, R. Fato, C. Castelluccio, M. Cavazzoni, G. Parenti Castelli, G. Lenaz,
Saturation kinetics of coenzyme Q in NADH and succinate oxidation in beef
heart mitochondria, FEBS Lett. 311 (1992) 107–109.
[67] G. Lenaz, A. Baracca, G. Barbero, C. Bergamini, M.E. Dalmonte, M. del Sole, M.
Faccioli, A. Falasca, R. Fato, M.L. Genova, G. Sgarbi, G. Solaini, Mitochondrial respi-
ratory chain super-complex I–III in physiology and pathology, Biochim. Biophys.
Acta 1797 (2010) 633–640.
[68] H. Rauchová, R. Fato, Z. Drahota, G. Lenaz, Steady-state kinetics of reduction of
Coenzyme Q analogs by glycerol-3-phosphate dehydrogenase in brown adipose
tissue mitochondria, Arch. Biochem. Biophys. 344 (1997) 235–241.
[69] R.G. Efremov, L.A. Sazanov, Structure of the membrane domain of respiratory
complex I, Nature 476 (2011) 414–420.
[70] R. Baradaran, J.M. Berrisford, G.S. Minhas, L.A. Sazanov, Crystal structure of the
entire respiratory complex I, Nature 494 (2013) 443–448.
[71] V.G. Grivennikova, R. Roth, N.V. Zakharova, C. Hagerhall, A.D. Vinogradov, The mito-
chondrial andprokaryotic proton-translocatingNADH:ubiquinoneoxidoreductases:
similarities and dissimilarities of the quinone-junction sites, Biochim. Biophys. Acta
1607 (2003) 79–90.
[72] C. Piccoli, R. Scrima, D. Boffoli, N. Capitanio, Control by cytochrome c oxidase of the
cellular oxidative phosphorylation system depends on the mitochondrial energy
state, Biochem. J. 396 (2006) 573–583.
[73] H. Schneider, J.J. Lemasters, C.R. Hackenbrock, Lateral diffusion of ubiquinone
during electron transfer in phospholipid- and ubiquinone-enriched mitochondrial
membranes, J. Biol. Chem. 257 (1982) 10789–10793.
[74] M. Battino, E. Ferri, A. Gorini, R.F. Villa, J.F. Rodriguez Huertas, P. Fiorella, M.L.
Genova, G. Lenaz, M. Marchetti, Natural distribution and occurrence of coenzyme
Q homologues, Membr. Biogeosci. 9 (1990) 179–190.
[75] E.Mileykovskaya, P.A. Penczek, J. Fang, V.K.Mallampalli, G.C. Sparagna,W.Dowhan,
Arrangement of the respiratory chain complexes in Saccharomyces cerevisiae
supercomplex III2IV2 revealed by single particle cryo-electron microscopy, J. Biol.
Chem. 287 (2012) 3095–23103.
[76] M. Trouillard, B. Meunier, F. Rappaport, Questioning the functional relevance of
mitochondrial supercomplexes by time-resolved analysis of the respiratory
chain, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) E1027–E1034.
[77] S.S. Gupte, E.S.Wu, L. Hoechli,M. Hoechli, K. Jacobson, A.E. Sowers, C.R. Hackenbrock,
Relationship between lateral diffusion, collision frequency, and electron transfer of
mitochondrial inner membrane oxidation–reduction components, Proc. Natl. Acad.
Sci. U. S. A. 81 (1984) 2606–2610.
[78] B. Muster, W. Kohl, I. Wittig, V. Strecker, F. Joos, W. Haase, J. Bereiter-Hahn, K.
Busch, Respiratory chain complexes in dynamic mitochondria display a patchy
distribution in life cells, PLoS ONE 5 (2010) e11910.
[79] V.Wilkens,W. Kohl, K. Busch, Restricted diffusion of OXPHOScomplexes indynamic
mitochondria delays their exchange between cristae and engenders a transitory
mosaic distribution, J. Cell Sci. 126 (2013) 103–116.
[80] E. Van den Brink-van der Laan, J.A. Killian, B. de Kruijff, Nonbilayer lipids affect pe-
ripheral and integral membrane proteins via changes in the lateral pressure proﬁle,
Biochim. Biophys. Acta 1666 (2004) 275–288.
[81] C. Osman, D.R. Voelker, T. Langer, Making heads or tails of phospholipids in mito-
chondria, J. Cell Biol. 192 (2011) 7–16.
[82] S.Y. Kang, H.S. Gutowsky, J.C. Hsung, R. Jacobs, T.E. King, D. Rice, E. Oldﬁeld, Nuclear
magnetic resonance investigation of the cytochrome oxidase–phospholipid inter-
action: a new model for boundary lipid, Biochemistry 18 (1979) 3257–3267.
[83] C. Lange, J.H. Nett, B.L. Trumpower, C. Hunte, Speciﬁc roles of protein–phospholipid
interactions in the yeast cytochrome bc1 complex structure, EMBO J. 20 (2001)
6591–6600.[84] E. Sedlák, N.C. Robinson, Phospholipase A(2) digestion of cardiolipin bound to bo-
vine cytochrome c oxidase alters both activity and quaternary structure, Biochem-
istry 38 (1999) 14966–14972.
[85] M. Fry, D.E. Green, Energized cation transport by complex III (ubiquinone-cytochrome
C reductase), Biochem. Biophys. Res. Commun. 97 (1980) 852–859.
[86] M. Fry, D.E. Green, Cardiolipin requirement for electron transfer in complex I and III
of the mitochondrial respiratory chain, J. Biol. Chem. 256 (1981) 1874–1880.
[87] K. Pfeiffer, V. Gohil, R.A. Stuart, C. Hunte, U. Brandt, M.L. Greenberg, H. Schägger,
Cardiolipin stabilizes respiratory chain supercomplexes, J. Biol. Chem. 278 (2003)
52873–52880.
[88] M. Zhang, E. Mileykovskaya, W. Dowhan, Gluing the respiratory chain together.
Cardiolipin is required for supercomplex formation in the inner mitochondrial
membrane, J. Biol. Chem. 277 (2002) 43553–43556.
[89] S.M. Claypool, Y. Oktay, P. Boontheung, J.A. Loo, C.M. Koehler, Cardiolipin deﬁnes
the interactome of the major ADP/ATP carrier protein of the mitochondrial inner
membrane, J. Cell Biol. 182 (2008) 937–950.
[90] T.Wenz, R. Hielscher, P. Hellwig, H. Schägger, S. Richers, C. Hunte, Role of phospho-
lipids in respiratory cytochrome bc(1) complex catalysis and supercomplex forma-
tion, Biochim. Biophys. Acta 1787 (2009) 609–616.
[91] K. Brandner, D.U. Mick, A.E. Frazier, R.D. Taylor, C. Meisinger, P. Rehling, Taz1, an
outer mitochondrial membrane protein, affects stability and assembly of inner
membrane protein complexes: implications for Barth Syndrome, Mol. Biol. Cell
16 (2005) 5202–5214.
[92] A.F. Neuwald, Barth syndrome may be due to an acyltransferase deﬁciency, Curr.
Biol. 7 (1997) R465–R466.
[93] M. McKenzie, M. Lazarou, D.R. Thorburn, M.T. Ryan, Mitochondrial respiratory
chain supercomplexes are destabilized in Barth Syndrome patients, J. Mol. Biol.
361 (2006) 462–469.
[94] F. Gonzalvez, M. D'Aurelio, M. Boutant, A. Moustapha, J.P. Puech, T. Landes, L.
Arnauné-Pelloquin, G. Vial, N. Taleux, C. Slomianny, R.J. Wanders, R.H. Houtkooper,
P. Bellenguer, I.M. Møller, E. Gottlieb, F.M. Vaz, G. Manfredi, P.X. Petit, Barth syn-
drome: cellular compensation of mitochondrial dysfunction and apoptosis inhibi-
tion due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene
mutation, Biochim. Biophys. Acta 1832 (2013) 1194–1206.
[95] G. Paradies, G. Petrosillo, M. Pistolese, F.M. Ruggiero, The effect of reactive oxygen
species generated from the mitochondrial electron transport chain on the cyto-
chrome c oxidase activity and on the cardiolipin content in bovine heart submito-
chondrial particles, FEBS Lett. 466 (2000) 323–326.
[96] G. Paradies, G. Petrosillo, M. Pistolese, F.M. Ruggiero, Reactive oxygen species affect
mitochondrial electron transport complex I activity through oxidative cardiolipin
damage, Gene 286 (2002) 135–141.
[97] G. Petrosillo, F.M. Ruggiero, N. Di Venosa, G. Paradies, Decreased complex III activity
inmitochondria isolated from rat heart subjected to ischemia and reperfusion: role
of reactive oxygen species and cardiolipin, FASEB J. 17 (2003) 714–716.
[98] G. Paradies, G. Petrosillo, V. Paradies, F.M. Ruggiero, Oxidative stress, mitochon-
drial bioenergetics, and cardiolipin in aging, Free Radic. Biol. Med. 48 (2010)
1286–1295.
[99] L. Böttinger, S.E. Horvath, T. Kleinschroth, C. Hunte, G. Daum, N. Pfanner, T. Becker,
Phosphatidylethanolamine and cardiolipin differentially affect the stability
of mitochondrial respiratory chain supercomplexes, J. Mol. Biol. 423 (2012)
677–686.
[100] K.M. Hatle, P. Gummadidala, N. Navasa, E. Bernardo, J. Dodge, B. Silverstrim, K.
Fortner, E. Burg, B.T. Suratt, J. Hammer, M. Radermacher, D.J. Taatjes, T. Thornton,
J. Anguita, M. Rincon, MCJ/DnaJC15, an endogenous mitochondrial repressor of
the respiratory chain that controls metabolic alterations, Mol. Cell. Biol. (2013)
2302–2314.
[101] M.E. Dalmonte, E. Forte, M.L. Genova, A. Giuffrè, P. Sarti, G. Lenaz, Control of respi-
ration by cytochrome c oxidase in intact cells: role of the membrane potential,
J. Biol. Chem. 284 (2009) 32331–32335.
[102] N. Khalifat, N. Puff, S. Bonneau, J.B. Fournier, M.I. Angelova, Membrane deformation
under local pH gradient: mimicking mitochondrial cristae dynamics, Biophys. J. 95
(2008) 4924–4933.
[103] N. Khalifat, J.B. Fournier, M.I. Angelova, N. Puff, Lipid packing variations induced by
pH in cardiolipin-containing bilayers: the driving force for the cristae-like shape
instability, Biochim. Biophys. Acta, Biomembr. 1808 (2011) 2724–2733.
[104] S.J. Ramirez-Aguilar, M. Keuthe, M. Rocha, V.V. Fedyaev, K. Kramp, K.J. Gupta, A.G.
Rasmusson, W.X. Schulze, J.T. van Dongen, The composition of plant mitochondrial
supercomplexes changes with oxygen availability, J. Biol. Chem. 286 (2011)
43045–43053.
[105] R. Acín-Peréz, D.L. Gatti, Y. Bai, G. Manfredi, Protein phosphorylation and preven-
tion of cytochrome oxidase inhibition by ATP: coupled mechanisms of energy me-
tabolism regulation, Cell Metab. 13 (2011) 712–719.
[106] R. Acín-Peréz, M. Russwurm, K. Gunnewig, M. Gertz, G. Zoidl, L. Ramos, J. Buck,
L.R. Levin, J. Rassow, G. Manfredi, C. Steegborn, A phosphodiesterase 2a isoform
localized to mitochondria regulates respiration, J. Biol. Chem. 286 (2011)
30423–30432.
[107] N. Deng, J. Zhang, C. Zong, Y. Wang, H. Lu, P. Yang, W. Wang, G.W. Young, Y. Wang,
P. Korge, C. Lotz, P. Doran, D.A. Liem, R. Apweiler, J.N. Weiss, H. Duan, P. Ping,
Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac
mitochondria, Mol. Cell. Proteomics 10 (2011)(M110.000117).
[108] P.A. Grimsrud, J.J. Carson, A.S. Hebert, S.L. Hubler, N.M. Niemi, D.J. Bailey, A. Jochem,
D.S. Stapleton, M.P. Keller, M.S. Westphall, B.S. Yandel, A.D. Attie, J.J. Coon, D.J.
Pagliarini, A quantitative map of the liver mitochondrial phosphoproteome reveals
posttranslational control of ketogenesis, Cell Metab. 16 (2012) 672–683.
[109] E. Hébert Chatelain, Src kinases are important regulators of mitochondrial func-
tions, Int. J. Biochem. Cell Biol. 45 (2013) 90–98.
442 M.L. Genova, G. Lenaz / Biochimica et Biophysica Acta 1837 (2014) 427–443[110] F. Bellomo, C. Piccoli, T. Cocco, S. Scacco, F. Papa, A. Gaballo, D. Boffoli, A. Signorile,
A. D'Aprile, R. Scrima, A.M. Sardanelli, N. Capitanio, S. Papa, Regulation by the cAMP
cascade of oxygen free radical balance in mammalian cells, Antioxid. Redox Signal.
8 (2006) 495–502.
[111] A. Iuso, S. Scacco, C. Piccoli, F. Bellomo, V. Petruzzella, R. Trentadue, M. Minuto, M.
Ripoli, N. Capitanio, M. Zeviani, S. Papa, Dysfunctions of cellular oxidative metabo-
lism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I,
J. Biol. Chem. 281 (2006) 10374–10380.
[112] M.C. Maj, S. Raha, T. Myint, B.H. Robinson, Regulation of NADH/CoQ oxidoreduc-
tase: do phosphorylation events affect activity? Protein J. 23 (2004) 25–32.
[113] S. Papa, D. de Rasmo, S. Scacco, A. Signorile, Z. Technikova-Dobrova, G. Palmisano,
A.M. Sardanelli, F. Papa, D. Panelli, R. Scaringi, A. Santeramo, Mammalian complex
I: a regulable and vulnerable pacemaker in mitochondrial respiratory function,
Biochim. Biophys. Acta 1777 (2008) 719–728.
[114] S. Raha, A.T. Myint, L. Johnstone, B.H. Robinson, Control of oxygen free radical
formation from mitochondrial complex I: roles for protein kinase A and pyruvate
dehydrogenase kinase, Free Radic. Biol. Med. 32 (2002) 421–430.
[115] D. de Rasmo, D. Panelli, A.M. Sardanelli, S. Papa, cAMP-dependent protein kinase
regulates the mitochondrial import of the nuclear encoded NDUFS4 subunit of
complex I, Cell. Signal. 20 (2008) 989–997.
[116] X. Zhao, I.R. Leon, S. Bak, M. Mogensen, K. Wrzesinski, K. Hojlund, O.N. Jensen,
Phosphoproteome analysis of functional mitochondria isolated from resting
human muscle reveals extensive phosphorylation of inner membrane protein
complexes and enzymes, Mol. Cell. Proteomics 10 (2011)(M110.000299).
[117] R. Acín-Peréz, E. Salazar, S. Brosel, H. Yang, E.A. Schon, G. Manfredi, Modulation
of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates
cytochrome oxidase defects, EMBO Mol. Med. 1 (2009) 392–406.
[118] R. Acín-Peréz, E. Salazar, M. Kamenetsky, J. Buck, L.R. Levin, G.Manfredi, Cyclic AMP
produced inside mitochondria regulates oxidative phosphorylation, Cell Metab.
9 (2009) 265–276.
[119] M. Rosca, P. Minkler, C.L. Hoppel, Cardiac mitochondria in heart failure: normal
cardiolipin proﬁle and increased threonine phosphorylation of complex IV,
Biochim. Biophys. Acta, Bioenerg. 1807 (2011) 1373–1382.
[120] N.V. Dudkina, M. Kudryashev, H. Stahlberg, E.J. Boekema, Interaction of complexes
I, III, and IV within the bovine respirasome by single particle cryoelectron tomog-
raphy, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 15196–15200.
[121] E. Schäfer, N.A. Dencher, J. Vonck, D.N. Parcej, Three-dimensional structure of
the respiratory chain supercomplex I1III2IV1 from bovine heart mitochondria,
Biochemistry 46 (2007) 12579–12585.
[122] T.M. Hildebrandt, Modulation of sulﬁde oxidation and toxicity in rat mitochon-
dria by dehydroascorbic acid, Biochim. Biophys. Acta, Bioenerg. 1807 (2011)
1206–1213.
[123] A. Panov, S. Dikalov, N. Shalbuyeva, R. Hemendinger, J.T. Greenamyre, J. Rosenfeld,
Species- and tissue-speciﬁc relationships between mitochondrial permeability
transition and generation of ROS in brain and liver mitochondria of rats and
mice, Am. J. Physiol. Cell Physiol. 292 (2007) C708–C771.
[124] G. Lenaz,M.L. Genova, Supramolecular organisation of themitochondrial respiratory
chain: a new challenge for themechanism and control of oxidative phosphorylation,
Adv. Exp. Med. Biol. 748 (2012) 107–144.
[125] H. Seelert, D.N. Dani, S. Dante, T. Hauss, F. Krause, E. Schäfer, M. Frenzel, A. Poetsch,
S. Rexroth, H.J. Schwassmann, T. Suhai, J. Vonck, N.A. Dencher, From protons to
OXPHOS supercomplexes and Alzheimer's disease: structure–dynamics–function
relationships of energy-transducing membranes, Biochim. Biophys. Acta 1787
(2009) 657–671.
[126] J. Hirst, M.S. King, K.R. Pryde, The production of reactive oxygen species by complex
I, Biochem. Soc. Trans. 36 (2008) 976–980.
[127] R. Fato, C. Bergamini, M. Bortolus, A.L. Maniero, S. Leoni, T. Ohnishi, G. Lenaz, Differ-
ential effects of mitochondrial Complex I inhibitors on production of reactive
oxygen species, Biochim. Biophys. Acta 1787 (2009) 384–392.
[128] J.R. Treberg, C.L. Quinlan, M.D. Brand, Evidence for two sites of superoxide produc-
tion by mitochondrial NADH-ubiquinone oxidoreductase (complex I), J. Biol.
Chem. 286 (2011) 27103–27110.
[129] M. Radermacher, T. Ruiz, T. Clason, S. Benjamin, U. Brandt, V. Zickermann, The
three-dimensional structure of complex I from Yarrowia lipolytica: a highly
dynamic enzyme, J. Struct. Biol. 154 (2006) 269–279.
[130] A. Baracca, F. Chiaradonna, G. Sgarbi, G. Solaini, L. Alberghina, G. Lenaz, Mitochon-
drial Complex I decrease is responsible for bioenergetic dysfunction in K-ras trans-
formed cells, Biochim. Biophys. Acta 1797 (2010) 314–323.
[131] Y.C. Chen, E.B. Taylor, N. Dephoure, J.M. Heo, A. Tonhato, I. Papandreou, N. Nath,
N.C. Denko, S.P. Gygi, J. Rutter, Identiﬁcation of a protein mediating respiratory
supercomplex stability, Cell Metab. 15 (2012) 348–360.
[132] V. Strogolova, A. Furness, M. Robb-McGrath, J. Garlich, R.A. Stuart, Rcf1 and Rcf2,
members of the hypoxia-induced gene 1 protein family, are critical components
of the mitochondrial cytochrome bc1-cytochrome c oxidase supercomplex, Mol.
Cell. Biol. 32 (2012) 1363–1373.
[133] M. Vukotic, S. Oeljeklaus, S. Wiese, F.N. Vögtle, C. Meisinger, H.E. Meyer, A.
Zieseniss, D.M. Katschinski, D.C. Jans, S. Jakobs, B. Warscheid, P. Rehling, M.
Deckers, Rcf1 mediates cytochrome oxidase assembly and respirasome forma-
tion, revealing heterogeneity of the enzyme complex, Cell Metab. 15 (2012)
336–347.
[134] G. Lenaz, Mitochondrial and reactive oxygen species. which role in physiology and
pathology? Adv. Exp. Med. Biol. 942 (2012) 93–136.
[135] M.G. Rosca, C.L. Hoppel, Mitochondria in heart failure, Cardiovasc. Res. 88 (2010)
40–50.
[136] S. Chen, Q. He, M.L. Greenberg, Loss of tafazzin in yeast leads to increased oxidative
stress during respiratory growth, Mol. Microbiol. 68 (2008) 1061–1072.[137] L.A. Gomez, J.S. Monette, J.D. Chavez, C.S. Maier, T.M. Hagen, Supercomplexes of the
mitochondrial electron transport chain decline in the aging rat heart, Arch.
Biochem. Biophys. 490 (2009) 30–35.
[138] M. Frenzel, H. Rommelspacher, M.D. Sugawa, N.A. Dencher, Ageing alters the su-
pramolecular architecture of Ox-Phos complexes in rat brain cortex, Exp. Gerontol.
45 (2010) 563–572.
[139] H. Cui, Y. Kong, H. Zhang, Oxidative stress, mitochondrial dysfunction, and aging,
J. Signal Transduct. (2012). http://dx.doi.org/10.1155/2012/646354 (Article ID
646354).
[140] L.A. Gómez, T.M. Hagen, Age-related decline in mitochondrial bioenergetics: does
supercomplex destabilization determine lower oxidative capacity and higher su-
peroxide production? Semin. Cell Dev. Biol. 23 (2012) 758–767.
[141] R. Acín-Peréz, M.P. Bayona-Bafaluy, P. Fernández-Silva, R. Moreno-Loshuertos, A.
Pérez-Martos, C. Bruno, C.T.Moraes, J.A. Enriquez, Respiratory complex III is required
to maintain complex I in mammalian mitochondria, Mol. Cell 13 (2004) 805–815.
[142] H. Schägger, R. de Coo, M.F. Bauer, S. Hofmann, C. Godinot, U. Brandt, Signiﬁcance
of respirasomes for the assembly/stability of human respiratory chain complex I, J.
Biol. Chem. 279 (2004) 36349–36353.
[143] F. Diaz, H. Fukui, S. Garcia, C.T. Moraes, Cytochrome c oxidase is required for the
assembly/stability of respiratory complex I in mouse ﬁbroblasts, Mol. Cell. Biol.
26 (2006) 4872–4881.
[144] U. Vempati, X. Han, C.T. Moraes, Lack of cytochrome c inmouse ﬁbroblasts disrupts
assembly/stability of respiratory complexes I and IV, J. Biol. Chem. 284 (2008)
4383–4391.
[145] E. Lamantea, F. Carrara, C. Mariotti, L. Morandi, V. Tiranti, M. Zeviani, A novel non-
sense mutation (Q352X) in the mitochondrial cytochrome b gene associated with
a combined deﬁciency of complexes I and III, Neuromuscul. Disord. 12 (2002)
49–52.
[146] M.D'Aurelio, C.D. Gajewski, G. Lenaz, G.Manfredi, Respiratory chain supercomplexes
set the threshold for respiration defects in humanmtDNAmutant cybrids, Hum.Mol.
Genet. 15 (2006) 2157–2169.
[147] M.A. Calvaruso, P. Willems, M. van den Brand, F. Valsecchi, S. Kruse, R. Palmiter,
J.A.M. Smeitink, L. Nijtmans, Mitochondrial complex III stabilizes complex I in the
absence of NDUFS4 to provide partial activity, Hum.Mol. Genet. 21 (2011) 115–120.
[148] B. Pineau, C. Mathieu, C. Gérard-Hirne, R. De Paepe, P. Chétrit, Targeting the NAD7
subunit inmitochondria restores a functional complex I and a wild type phenotype
in the Nicotiana sylvestris CMS II mutant lacking nad7, J. Biol. Chem. 280 (2005)
25994–26001.
[149] C. Ugalde, R.J. Janssen, L.P. Van den Heuvel, J.A. Smeitink, L.G. Nijtmans, Differences
in the assembly and stability of complex I and other OXPHOS complexes in
inherited complex I deﬁciency, Hum. Mol. Genet. 13 (2004) 659–667.
[150] L.I. Grad, D. Lemire, Mitochondrial complex I mutations in Caenorhabditis elegans
produce cytochrome c oxidase deﬁciency, oxidative stress and vitamin-response
lactic acidosis, Hum. Mol. Genet. 13 (2004) 303–314.
[151] L.I. Grad, D. Lemire, Riboﬂavin enhances the assembly of mitochondrial cyto-
chrome c oxidase in C. elegans NADH ubiquinone reductase mutants, Biochim.
Biophys. Acta 1757 (2006) 115–122.
[152] W. Suthammarak, Y.Y. Yang, P.G. Morgan, M.M. Sedensky, Complex I function
is defective in complex IV-deﬁcient Caenorhabditis elegans, J. Biol. Chem. 284
(2009) 6425–6435.
[153] W. Suthammarak, P.G. Morgan, M.M. Sedensky, Mutations in mitochondrial
complex III uniquely affect complex I in Caenorhabditis elegans, J. Biol. Chem. 285
(2010) 40724–40731.
[154] D. Moreno Lastres, F. Fontanesi, I. García-Consuegra, M.A. Martín, J. Arenas, A.
Barrientos, C. Ugalde, Mitochondrial Complex I plays an essential role in human
respirasome assembly, Cell Metab. 15 (2012) 324–335.
[155] K.B. Choksi, W.H. Boylston, J.P. Rabek, W.R. Widger, J. Papaconstantinou, Oxidative-
ly damaged proteins of heart mitochondrial electron transport complexes,
Biochim. Biophys. Acta 1688 (2004) 95–101.
[156] G. Paradies, G. Petrosillo, M. Pistolese, N. Di Venosa, A. Federici, F.M. Ruggiero,
Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: in-
volvement of reactive oxygen species and cardiolipin, Circ. Res. 94 (2004) 53–59.
[157] F. Diaz, J.A. Enriquez, C.T. Moraes, Cells lacking Rieske iron–sulfur protein have a
reactive oxygen species-associated decrease in respiratory complexes I and IV,
Mol. Cell. Biol. 32 (2012) 415–429.
[158] A. Ghelli, C.V. Tropeano,M.A. Calvaruso, A.Marchesini, L. Iommarini, A.M. Porcelli, C.
Zanna, V. De Nardo, A. Martinuzzi, F. Wibrand, J. Vissing, I. Kurelac, G. Gasparre, N.
Selamoglu, F. Daldal, M. Rugolo, The cytochrome b p. 278Y N C mutation causative
of a multisystem disorder enhances superoxide production and alters supramolec-
ular interactions of respiratory chain complexes, Hum. Mol. Genet. 22 (2013)
2141–2151.
[159] P. Lanciano, B. Khalfaoui-Hassani, N. Selamoglu, A. Ghelli, M. Rugolo, F. Daldal,
Molecular mechanisms of superoxide production by complex III: a bacterial versus
humanmitochondrial comparative case study, Biochim. Biophys. Acta 1827 (2013)
1332–1339.
[160] B. Sumegi, P.A. Srere, Complex I binds several mitochondrial NAD-coupled dehy-
drogenases, J. Biol. Chem. 259 (1984) 15040–15045.
[161] J. Ovadi, Y. Huang, H.O. Spivey, Binding of malate dehydrogenase and NADH
channeling to complex I, J. Mol. Recognit. 7 (1994) 265–272.
[162] T. Fukushima, R.V. Decker, W.M. Anderson, H.O. Spivey, Substrate channeling of
NADH and binding of dehydrogenases to complex I, J. Biol. Chem. 264 (1989)
16483–16488.
[163] A.B. Kotlyar, E. Maklashina, G. Cecchini, Absence of NADH channeling in coupled
reaction of mitochondrial malate dehydrogenase and complex I in alamethicin-
permeabilized rat liver mitochondria, Biochem. Biophys. Res. Commun. 318
(2004) 987–991.
443M.L. Genova, G. Lenaz / Biochimica et Biophysica Acta 1837 (2014) 427–443[164] N. Anilkumar, A. Sirker, A.M. Shah, Redox sensitive signaling pathways in cardiac
remodeling, hypertrophy and failure, Front. Biosci. 14 (2009) 3168–3187.
[165] T. Ide, H. Tsutsui, S. Kinugawa, N. Suematsu, S. Hayashidani, K. Ichikawa, H. Utsumi,
Y. Machida, K. Egashira, A. Takeshita, Direct evidence for increased hydroxyl radi-
cals originating from superoxide in the failing myocardium, Circ. Res. 86 (2000)
152–157.
[166] P.D. Ray, B.W. Huang, Y. Tsuji, Reactive oxygen species (ROS) homeostasis and
redox regulation in cellular signaling, Cell. Signal. 24 (2012) 981–990.
[167] B. D'Autréaux, M.B. Toledano, ROS as signalling molecules: mechanisms that gen-
erate speciﬁcity in ROS homeostasis, Nat. Rev. Mol. Cell Biol. 8 (2007) 813–824.
[168] S.P. Whelan, B.S. Zuckerbraun, Mitochondrial signaling: forwards, backwards, and
in between, Oxid. Med. Cell. Longev. (2013) 351613.
[169] S.M. Jazwinski, The retrograde response: whenmitochondrial quality control is not
enough, Biochim. Biophys. Acta 1833 (2013) 400–409.
[170] K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, M. Yamamoto,
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2
through binding to the amino-terminal Neh2 domain, Genes Dev. 13 (1999)
76–86.
[171] G. Benard, N. Bellance, C. Jose, R. Rossignol, Relationships between mitochondrial
dynamics and bioenergetics, in: L.B. Dordrecht (Ed.), Mitochondrial Dynamics
and Neurodegeneration, Springer, 2011, pp. 47–68.
[172] G. Tasseva, H.D. Bai, M. Davidescu, A. Haromy, E. Michelakis, J.E. Vance, Phosphati-
dylethanolamine deﬁciency in mammalian mitochondria impairs oxidative phos-
phorylation and alters mitochondrial morphology, J. Biol. Chem. 288 (2013)
4158–4173.
[173] G. Benard, T. Trian, N. Bellance, P. Berger, J. Lavie, C. Espil-Taris, C. Rocher, S.
Eimer-Bouillot, C. Goizet, K. Nouette-Gaulain, T. Letellier, D. Lacombe, R. Rossignol,
Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics
in response to pathogenic respiratory chain dysfunction, Antioxid. Redox Signal.
19 (2013) 350–365.[174] T. Letellier, R. Heinrich, M. Malgat, J.P. Mazat, The kinetic basis of threshold effects
observed in mitochondrial diseases: a systemic approach, Biochem. J. 302 (1994)
171–174.
[175] S. Moncada, J.P. Bolanos, Nitric oxide, cell bioenergetics and neurodegeneration,
J. Neurochem. 97 (2006) 1676–1689.
[176] S. Vankoningsloo, A. De Pauw, A. Houbion, S. Tejerina, C. Demazy, F. de Longueville,
V. Bertholet, P. Renard, J. Remacle, P. Holvoet, M. Raes, T. Arnould, CREB activation
induced by mitochondrial dysfunction triggers triglyceride accumulation in
3 T3-L1 preadipocytes, J. Cell Sci. 119 (2006) 1266–1282.
[177] L. Mercy, A. Pauw, L. Payen, S. Tejerina, A. Houbion, C. Demazy, M. Raes, P. Renard,
T. Arnould, Mitochondrial biogenesis in mtDNA-depleted cells involves a
Ca2+-dependent pathway and a reduced mitochondrial protein import, FEBS J.
272 (2005) 5031–5055.
[178] M.G. Rosca, C.L. Hoppel, New aspects of impaired mitochondrial function in heart
failure, J. Bioenerg. Biomembr. 41 (2009) 107–112.
[179] M.G. Rosca, E.J. Vazquez, J. Kerner, W. Parland, M.P. Chandler, W. Stanley, H.N.
Sabbah, C.L. Hoppel, Cardiacmitochondria in heart failure: decrease in respirasomes
and oxidative phosphorylation, Cardiovasc. Res. 80 (2008) 30–39.
[180] D.C. Wallace, Mitochondria and cancer, Nat. Rev. Cancer 12 (2012) 685–698.
[181] J. Lu, L.K. Sharma, Y. Bai, Implications of mitochondrial DNA mutations and mito-
chondrial dysfunction in tumorigenesis, Cell Res. 19 (2009) 802–815.
[182] K. Polyak, Y. Li, H. Zhu, C. Lengauer, J.K. Willson, S.D. Markowitz, M.A. Trush, K.W.
Kinzler, B. Vogelstein, Somatic mutations of the mitochondrial genome in human
colorectal tumours, Nat. Genet. 20 (1998) 291–293.
[183] L.K. Sharma, H. Fang, J. Liu, R. Vartak, J. Deng, Y. Bai, Mitochondrial respiratory
complex I dysfunction promotes tumorigenesis through ROS alteration and AKT
activation, Hum. Mol. Genet. 20 (2011) 4605–4616.
[184] G. Gasparre, A.M. Porcelli, G. Lenaz, G. Romeo, Relevance of mitochondrial genetics
and metabolism in cancer development, Cold Spring Harb. Perspect. Biol. 5
(2013)(pii: a011411).
